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Abstract 
This thesis, presented as a thesis incorporating publications, examines the 
effects of phacoemulsification, uveitis and high intensity focused ultrasound on 
the aqueous humour dynamics. 
The interplay between aqueous humour parameters are complex. The impacts of 
various pathologies and pharmacological changes in glaucoma and healthy 
subjects have been extensively investigated. However, the evidence on the 
modern cataract surgery and the aqueous humour dynamics has not been 
consistent. It has been shown in previous studies that phacoemulsification 
reduces intraocular pressure (IOP). But the mechanism through which IOP is 
reduced is not fully understood. I performed electronic Schiøtz tonography to 
measure outflow facility before and after phacoemulsification. I demonstrated 
that the tonographic outflow facility (TOF) enhancement as a result of cataract 
surgery in open angle glaucoma (OAG) cases is responsible for IOP reduction. 
On the other hand, uveitis can be a sight threating condition especially due to its 
sequlae such as glaucoma. The animal studies on the effects of uveitis on the 
aqueous humour dynamics are limited. They are mainly focused on the acute 
phase of the intraocular inflammation. However, only two human studies in 
assessing the aqueous humour dynamics are available to date. But neither has 
been comprehensive nor comparative with healthy subjects or quiescent eyes. In 
my study of the uveitis and aqueous humour dynamics changes, I have 
 3 
illustrated that raised IOP is mainly due to compromised TOF, whilst 
the-aqueous flow rate and the uveoscleral outflow remained unchanged. 
There is a plethora of new treatment modalities emerging in the field of 
glaucoma every day. One of these new additions is high intensity 
focused-ultrasound (HiFU). Although it reduces IOP to some extent the 
mechanism of action is unclear. There have been some speculations that it may 
affect the aqueous flow rate and the uveoscleral outflow. Also, there have been 
no studies on the effects of HiFU on the aqueous humour dynamics especially 
with glaucoma medication washout. In my study of the effect of HiFU on 
aqueous humour dynamics, I have shown that IOP at three months post 
procedure was reduced by 12% whilst aqueous flow rate was reduced by 10%. 
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Chapter 1| Introduction 
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Aqueous humour dynamics has been studied extensively to clarify the 
mechanism of action of new glaucoma medications. Additionally, it has been 
utilised to understand the effects of more commonly performed ophthalmic 
procedures such as cataract surgery and laser trabeculoplasty. However, the 
results of studies in cataract surgery have been inconsistent. Therefore, the 
unmet need for elucidating the alterations of aqueous humour dynamics 
parameters exists. 
Newer technologies harness novel techniques to treat glaucoma more 
effectively and more precisely. One example is high intensity focused 
ultrasound (HiFU). This treatment modality targets ciliary bodies in a titrated 
and more controlled manner by applying ultrasonic energy to the eye and 
specifically ciliary bodies to reduce aqueous flow rate. This subsequently 
reduces intraocular pressure (IOP). To date no studies have investigated the 
aqueous humour dynamics changes after cyclodestructive therapy. 
Moreover, evaluating aqueous humour dynamics has enabled investigators to 
assess the effect of various systemic conditions (such as diabetes, ageing, etc.) 
and ocular conditions (including uveitis) on the aqueous humour dynamics 
parameters. There are only a few studies that have explored the changes of 
the-aqueous humour dynamics in a small number of patients with Fuchs 
heterochromic cyclitis (Johnson et al., 1983). However, in active uveitis (such 
as in Fuch’s heterochromic cyclitis) the aqueous-blood barrier is broken and 
therefore, it poses a challenge in aqueous humour dynamics 
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measurements.-This is particularly crucial when fluorophotometry is utilised in 
assessing aqueous flow rate. Furthermore, to date there are no studies 
investigating uveitic glaucoma and comparing it with healthy subjects with 
hypotensive medication washout. 
Consequently, we still lack understanding in some of the areas which have been  
highlighted. The basis of this thesis is to shed some light in some of these areas. 
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Chapter 2|Materials and methods 
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Aqueous humour dynamics 
In this chapter, I will scrutinise the available evidence on each aqueous humour 




• Aqueous humor in the history 
• Aqueous humor flow rate 
• Trabecular meshwork outflow (outflow facility) 
• Unconventional outflow (uveoscleral outflow) 
• Episcleral venous pressure 
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Aqueous humour in the history 
 
Until the turn of the 20th century it was a common belief that aqueous humour is 
a stagnant fluid within the eye. Leber (Leber, 1903) described a model of 
aqueous humour dynamics which entailed that aqueous humour is produced in 
the posterior chamber and then traversed through the pupil into the anterior 
chamber. But then Seidel’s work (Seidel, 1921) unravelled the mystery of 
the-aqueous humor dynamics further. He perfused the enucleated rabbit’s eye 
with the indigo carmine dye from a reservoir which was attached to the eye. He 
observed the displacement of the dye, between the eye and the chamber. 
Depending on the height of the reservoir, the dye displaced towards or away 
from the reservoir. Then he increased the height of the reservoir and he noticed 
that the fluid is flowing through the tubing to the eye from the reservoir. 
Subsequently the dye flowed towards the episcleral veins and filled them. He 
deduced that aqueous humour is constantly made and replaced by fresh newly 
produced fluid. The origin of aqueous humour, however, was not elucidated at 
that time. Boerhavve (Boerhaave, 1771) was the first person to discover the 
existence of aqueous veins. Later Ascher (Ascher, 1949) demonstrated that 
episcleral veins contain aqueous humour and they have a role in removing the 
aqueous humour from the eye. Goldmann (Goldmann, 1950) administered the 
fluorescein systemically and observed that it first started to appear in the 
anterior chamber of the eye and then eventually in the episcleral veins. 
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Sir-Stewart Duke-Elder (Duke-Elder, 1932) suggested that the aqueous is the 
filtration of plasma. Jonas Friedenwald (Cogan et al., 1955) was the advocate of 
the notion that aqueous humour is the ultrafiltration of plasma. Over the years, 
the focus on the source of aqueous humour formation narrowed down further. 
At the beginning, the attention was on an organ (i.e. the eye) and later it was 
more focused towards sections of the eye (i.e. ciliary processes) and even more 
precisely pointed to the ciliary epithelium; Later it was even further drilled 
down to water channels called aquaporins (Yamaguchi et al., 2006) which 
actively work as a conduit for water in and out of cells. 
We now know that the aqueous humour drains through the 
trabecular-meshwork, then the Schlemm’s canal, collector channels, aqueous 
veins, episcleral veins and finally into the systemic venous system. 
Different aqueous outflow pathways exist; conventional and unconventional. It 
is assumed that some of the fluid drained backwards into the vitreous and optic 
nerve; however, the amount of the flow is very negligible. The main 
unconventional pathway, however, is via the uveoscleral outflow. Overby 
(Johnson et al., 2017) and associates suggested some methods to measure this in 
the animal models. This pathway accounts for about 20% of the outflow. 
Most-of the outflow is through the trabecular meshwork (conventional 
pathway). Each aqueous humour parameter will be explained in more details in 
the following pages. 
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Aqueous humour flow rate 
 
Several methods exist to measure the aqueous flow rate including direct and 
indirect techniques. The ideal method is repeatable, does not change the 
intraocular pressure (IOP) and it is indirect. I will explore each method 
separately in the following paragraphs. 
Several direct methods were introduced during the 1950s. The principals were 
that the eye was cannulated and the infusion at a known rate and known 
pressure level were utilised and subsequently the drainage was measured 
directly (Brubaker and Riley, 1972; Brubaker and Worthen, 1973; Kaufman, 
1979; Bill and Barany, 1966; Langham and Taylor, 1960; Langham and 
Rosenthal, 1966). However, these methods were invasive, and they were not 
feasible or ethical to be carried out on humans routinely. The next best option 
was indirect methods of testing. One of these methods was the systemic 
injection of fluorescein which was first described by Ehrlich (Ehrlich, 1882) 
approximately over a century ago. He administered fluorescein systemically in 
rabbits and then the fluorescein started to appear in the anterior chamber of 
the-eye. Lindner (Lindner, 1920) measured the amount of fluorescein in 
the-anterior chamber quantitatively. Amsler and Huber (Amsler and Huber, 
1946) improved the existing technique and simplified it. Their method was 
utilised in other subsequent studies of assessing aqueous-blood barrier by other 
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researchers (Gaedertz and Wittgenstein, 1928; Lugossy, 1959). Over the past 
six decades, there has been several modifications to the fluorescein technique. 
• Barany and Kinsey (Barany and Kinsey, 1949), created a method to 
measure aqueous flow rate using the disappearance of fluorescein from 
the anterior chamber. 
• In 1950s, Goldmann (Goldmann, 1950, 1951) enhanced the existing 
methodology and increased the accuracy of the measurement of 
fluorescein in a more quantitative fashion. In his method, Goldmann 
measured the amount of unbound fluorescein in plasma and anterior 
chamber after systemic administration of fluorescein. This was the first 
attempt to measure aqueous humor flow rate in humans quantitatively. 
Nevertheless, his technique was so complex that later not many 
investigators adopted Goldmann’s technique. 
• Langley and MacDonald (Langley and MacDonald, 1952) applied 
fluorescein topically and named their technique the “dye-dilution 
method”. They proposed that the aqueous humour flow rate could be 
extrapolated from the rate of dilution of the aqueous. Later, Langham and 
Wybar (Langham and Wybar, 1954) devised the first slit lamp 
fluorophotometer. 
• Holm and associates (Holm and Wiebert, 1968; Holm and Krakau, 1966; 
Holm, 1968) facilitated another technique called “pupillary bubble”. 
In-this method, they applied fluorescein topically and observed the 
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enlargement of the clear aqueous fluid as it entered the anterior chamber, 
the fluorescein mixed with aqueous humour. However, from a technical 
point of view, it was challenging to measure the volume of aqueous as it 
expanded. 
• Maurice (Maurice, 1963) explored the fluorescein tracer in the aqueous 
humour studies extensively. He had several reasons for choosing 
fluorescein as a suitable tracer (McLaren and Brubaker, 1985; McLaren, 
2009; Brubaker, 1982). His reasons were as followed: 
• It is not metabolised by the eye and it could disappear through 
different paths 
• It penetrates via the epithelium of the cornea and washes out through 
the tear film 
• It penetrates through the limbus 
• It enters the endothelium and gains access to the aqueous humour 
In the 1960s Maurice (Maurice, 1963) introduced an enhanced model of 
the-fluorophotometer with a significant reduction in the signal-noise ratio. 
Subsequently Jones and Maurice (Jones and Maurice, 1966) collaboratively 
devised an improved version of their original fluorophotometer which was 
convenient to use, and reproducible with the least ocular disturbance. 
Additionally, their method accurately measured the aqueous flow rate from a 
modified dye-dilution technique. 
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A decade later Yablonski (Yablonski et al., 1978), modified Jones and 
Maurice’s “corneal depot” technique by applying fluorescein topically or 
through iontophoresis. Furthermore, this technique is not affected by the iris 
colour. The measurements would still be accurate and repeatable unlike the 
Jones and Maurice’s method. Also, the drug induced changes of the aqueous 
flow rate were captured within a few hours by facilitating the 
Yablonski-protocol. These changes have been incorporated into the commercial 
fluorophotometer device software. The commercially available 
fluorophotometers operate based on the Waltman and Kaufman’s slit lamp 
fluorophotometer (Waltman and Kaufman, 1970). This is based upon 
appearance and disappearance of fluorescein in the anterior chamber of the eye. 
The beauty of utilising fluorescein in the aqueous humour flow rate 
measurement is to enable the investigators to assess the aqueous flow rate in an 
un-anaesthetised eye. This is more convenient and safer than other methods 
mentioned earlier. Additionally, topical application of fluorescein eliminates the 
risk of the systemic side effects of fluorescein administration including 
anaphylaxis reaction. In modified Jones and Maurice’s “corneal depot” 
technique, it is crucial to saturate the cornea uniformly by using topical 
fluorescein a few hours (at least 8 hours) (waiting period) prior to the 
measurement of the aqueous humour flow rate determination (Brubaker, 1982; 
R. Brubaker, 2004; Brubaker and McLaren, 1985). 
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Currently two different types of fluorophotometers exist: slit lamp mounted and 
stand-alone scanning devices. The advantage of the former is a direct 
visualisation of the target which is useful in guiding the subjects to stabilise 
their eyes during measurement. But the downside is that the movements of the 
eye create artefacts. The issue with eye movement can be overcome in scanning 
fluorophotometers by encouraging the subjects to maintain their gaze at the 
light target (within the eyepiece of the device) during fluorophotometry. 
The process commences on the previous night. The participants are instructed to 
self-administer 3 to 5 drops of high concentration of fluorescein sodium 2% 
(Minims; Bausch & Lomb, Kingston-upon-Thames, UK) topically into both 
eyes at 5-minute intervals at 10 pm, the night before the test (depending on their 
age (age<25 years, 5 drops; age 26–35 years, 4 drops; >35 years of age, 3 
drops) (Brubaker et al., 2001). It has been noted that during the first 3 hours 
after the fluorescein application, the concentration of fluorescein in the cornea 
falls, while the concentration of fluorescein in the anterior chamber rises. After 
this preliminary stage, the fluorescein concentration reaches a steady state and 
then both fall in a very continuous and linear fashion. Some of the fluorescein 
penetrates the epithelium of the cornea (approximately under 500 ng). Then 
reaches the stroma and penetrates the endothelium and finally enters the anterior 
chamber. When the corneal stroma is saturated evenly, the concentration of 
fluorescein is measured in the cornea and the anterior chamber simultaneously. 
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The aqueous flow rate is estimated using the Jones and Maurice equation 
(Equation 1) (Jones and Maurice, 1966): 






mt is the change in the total amount (mass) of fluorescein in the cornea and 
anterior chamber on t time, Ca is the mean concentration of fluorescein in the 
anterior chamber between each interval and d is the amount of fluorescein 
which is lost through diffusion into the vessels. mt is calculated from the 
formula below: 
𝑚𝑡 = 𝑣𝑐𝐶𝑐 + 𝑣𝑎𝐶𝑎 
In this equation, vc and va are the volumes of cornea and anterior chamber 
respectively and Cc and Ca is the concentration of fluorescein in the cornea and 
anterior chamber respectively (these could be calculated utilising Pentacam or 
using pre-assumed values). 
Commercially available fluorophotometers were initially designed to detect 
blood-barrier breakdown in diabetic retinopathy cases in the early stages of the 
disease before the clinical signs become apparent (Plehwe et al., 1989). 
Fluorophotometry for the purpose of aqueous humour flow rate measurement is 
performed in both eyes with a scanning ocular fluorophotometer from 9 AM to 
12 PM (FM-2, Fluorotron Master ocular fluorophotometer; OcuMetrics, 
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Mountain View, CA). The Fluorotron system is made up of three major 
components (Figure 2-1). 
 
• The electro-optic system (optic head) containing excitation and detection 
modules 
• The computer 
• The mechanical section 
 
Figure 2-1 Shows Fluorotron machine 
 
The optic head is a fluorophotometer which delivers a specifically focused 
excitation beam (440-480 nm) (from a halogen lamp) of blue light into the 
ocular cavity and then receives the resulting fluorescent green light and directs 
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it into a photon counting photomultiplier tube (531-634 nm). By changing the 
focal plane every 0.25 mm, as many as 149 sequential readings are made along 
an axis from a position posterior to the retina to a position anterior to the cornea. 
The operation of the optic head is controlled by the computer, prompting the 
operator through the entire procedure. The operator only aligns the eye and 
starts the scan. The scan is then automatically performed and displayed on the 
screen and printed in graphic and digital formats. Scan and patient data are 
stored electronically. The computer is used to process the data by using the 
appropriate program (www.ocumetrics.com). 
Optic head features 
Depth of 
Resolution  
2 mm at 3% peak signal 
Sensitivity  0.1 ng/ml fluorescein  
(3x background fluctuations) 
Reproducibility 5% with solutions < 5 ng/ml 
3% with solutions > 5 ng/ml 
The depth of resolution is the distance that a very large signal is reduced to 3%. 
Background noise in itself does not affect sensitivity as long as it is constant as 
it can be subtracted out. It is the fluctuation in background that can be 
problematic. That is why 3x the fluctuation in background is the limit to 
sensitivity. 
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Reproducibility is related to signal (very directly in a photon counting system 
like the Fluorotron), so the deviation in reproducibility is specified for lower 
concentrations versus higher concentrations. 
Some of the fluorescence emitted in the eye is detected by the pick-up optics 
which only gather light coming from the focal plane of the illuminating beam. 
The intersection of the illuminating (excitation) beam and pick-up optical path 
defines a small area inside the anterior chamber called the “focal diamond” 
(Figure 2-2). This is the area where the fluorescence is detected by 
photodetectors. The device is fitted with two green filters in front of the 
photodetectors. This enables the detection of only light in the fluorescence 
bandwidth within the focal diamond. The measurement area is scanned, and the 
photodetectors count the number of photons emitted from the scanned area. 
 
Figure 2-2. Depiction of excitation and fluorescence emitted lights and focal diamond (the 
intersection between the blue and green lights) 
Concentration of fluorescein in the cornea
Excitation blue light
Fluorescent green light
Concentration of fluorescein in the anterior chamber 
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The aqueous humour flow rate is determined using dedicated software provided 
with the fluorophotometer. Triplicate scans are collected and repeated at hourly 
intervals for four measurements to determine the aqueous flow rate (Ft). 
Aqueous humour flow rate is the volume of aqueous humour produced by the 
ciliary body per unit of time (Yablonski et al., 1978). 
𝐹𝑡 = 𝐾𝑜 𝑥 𝑉𝑎 
 
where, Ft is the aqueous humour flow rate (µL/min), Va is the volume of the 
anterior chamber (µL), and Ko is the loss coefficient due to bulk flow and 
diffusion from the anterior chamber (minutes-1). Ko can be thought of as the 
fraction of anterior chamber volume clearance of fluorescein every minute, due 
to aqueous flow. 
To calculate the aqueous humour flow rate , the Fluorotron software uses 
default variables that can be changed by the operator as necessary (Figure 2-3): 
• Corneal volume default value, 70µL 
• Anterior chamber volume default value, 174 µL 
• Central corneal thickness (CCT) of each patient, in µm (I have used each 
patient’s central corneal thickness instead of using the 500 µm default 
value to correct for the depth of the focal diamond). 
Once the relationship between the concentrations of fluorescein in the cornea 
and the anterior chamber becomes steady, the program can determine Ko and 
aqueous flow (Ft), as described in detail elsewhere. 
The aqueous turnover analysis results are: 
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• Corneal slope 
• Correlation coefficient: shows how closely the linear regression lines fit 
the cornea/anterior chamber points using the least squares analysis. 
• D avg: Ratio of the midpoints of the two best-fit lines on the graph 
• Ka.ca: diffusion coefficient referred to the anterior chamber volume, from 
cornea to anterior chamber 
• Ko: diffusion coefficient due to outflow from the anterior chamber 
• Aqueous turnover: Volume of aqueous passing through the anterior 




Figure 2-3 Fluorotron output data. The upper line shows the corneal concentration of fluorescein and 
the lower line depicts the anterior chamber fluorescein concentration. The software allows the 
operator to ignore unreliable measurements and labels them as “ignored”. In this diagram all points 
have been considered as “normal” 
Homogenous distribution of fluorescein in the cornea and anterior chamber is 
crucial in fluorophotometry (Brubaker and McLaren, 1985). To improve the 
uniformity of distribution of fluorescein in the anterior chamber, patients should 
be instructed to move their eyes to different directions before measurements. In 
terms of corneal distribution uniformity, participants should be advised to 
administer fluorescein in the middle of night (McLaren, 2009). This allows the 
corneal stroma to become saturated with fluorescein and create an equilibrium 
between stromal and aqueous fluorescein concentration. 
When the fluorescein is applied topically, the aqueous humour flow rate is 
measured at 2.4±0.6 µl/min in healthy White Caucasian individuals (McLaren, 
2009). There is no marked difference between men and women in terms of their 
aqueous humour flow rate. The aqueous humour flow rate is not significantly 
different in African/Caribbean and White Caucasian individuals (2.36 vs 
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2.26-ml/min) (Beltran-Agullo et al., 2011). The aqueous humour flow rate 
degrades 4% per each decade of life. There are different theories explaining this 
phenomenon including decline in number of ciliary epithelial cells, aging 
changes in the ciliary body structure and neuronal/hormonal alteration with age 
(Brubaker, 1991). Although, from 20 to 80 years of age the rate of aqueous 
humour flow rate reduces by 25%, the anterior chamber depth in phakic eyes is 
reduced by 40% (due to lens enlargement) and consequently the aqueous 
turnover is increased by 20% over a life time (McLaren, 2009; Toris et al., 
1999). The aqueous flow rate can vary in some situations during day and wake 
time except sleep (and supine position), in which the flow rate is almost halved 
compared to wakefulness (1.3±0.4 µl/min) (Brubaker, 1982; Brubaker and 
McLaren, 1985; R. F. Brubaker, 2004; Larsson et al., 1995; Brubaker, 1991). In 
recumbent position venous return is increased and consequently the 
episcleral-venous pressure is increased. Therefore, in order to maintain the 
steady state of normal IOP in the eye, the aqueous flow rate is reduced. This 
suggests a circadian rhythm for the aqueous humour flow rate. The reason for 
this change is postulated to be related to several factors including reduced 
circulating catecholamines during sleep (sympathetic system is a drive for 
production of aqueous humour during wakefulness) and increased episcleral 
venous pressure. Nonetheless, this is just a simplification of a very complex 
system. The aqueous humour flow rate is highest in the morning (approximately 
3.0 µl/min) while it is at its lowest at night-time during sleep when it is halved. 
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Water drinking test have shown to reduce aqueous flow rate for a very short 
period of time after the test, before it is restoring to pre-test values (Diestelhorst 
and Krieglstein, 1994; Arora et al., 2013).  
To be able to reliably utilise fluorophotometry technique, few assumptions must 
be met (Brubaker and McLaren, 1985). They are listed as following: 
• The time between the application of fluorescein and its measurement is 
long enough to allow saturation of the corneal stroma to take place and 
create constant ratio between cornea and anterior chamber. Additionally, 
the ratio of corneal stromal and cameral fluorescence is constant. 
• The aqueous humour flow rate and the fluorescein penetration through 
corneal stroma is in a steady state. 
• The stromal volume is 70 µl (this is an assumed value but could be 
measured with Pentacam). I have used the assumed value of 70 µl in my 
projects. 
• The fluorescein diffusional loss is 0.25 µl/min (intact blood-aqueous 
barrier and uninflamed eye)(McLaren, 2009; Brubaker, 1982, 1991). In 
the presence of inflammation, the aqueous-blood barrier is broken which 
allows proteins (flare) to leak into the anterior chamber. This will 
subsequently increase scattered light which can then diminish the 
measured fluorescence. Additionally, fluorescein can bind to proteins and 
its fluorescence is quenched and decreased which in turn has an impact 
on the fluorescence signal (personal communication with 
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Dr-Jay-McLaren). Another condition which can influence the diffusional 
loss is rubeosis iridies. 
• The iris-lens diaphragm is intact (phakic eye) and there is no artificial 
connection between the anterior and posterior chamber (i.e. peripheral 
iridotomy or iridectomy). Consequently, the presence of intraocular 
inflammation, intraocular surgeries with a breach of the iris-lens 
diaphragm such as cataract surgery, aphakia and widely dilated pupil 
would render this technique obsolete. 
• At least a one-hour time interval between each measurement is required. 
In addition, to improve the accuracy, the measurements should be 
repeated several times and the average measurement should be taken into 
account. 
• The amount of measured fluorescence of the anterior chamber is 99%. 
This is from the anterior chamber - and 1% stromal fluorescence. It can 
also be said that any condition which compromises the corneal clarity 
may make the fluorophotometry worthless. 
• The amount of fluorescein in the cornea should be ≥200 ng/ml to reduce 
the corneal autofluorescence and stromal binding of fluorescein. 
• The focal diamond of the fluorophotometer should be aimed on the 
cornea. The intersection of the illuminating beam and pick-up optical 
path defines a small area inside the anterior chamber called the “focal 
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diamond”. This is the area where the fluorescence in the cornea and 
anterior chamber is detected by photodetectors. 
• Corneal integrity and pathology can affect diffusion of fluorescein; 
therefore, it is crucial that the cornea is intact. 
There is a sequence of events that leads to the production of aqueous humour 
fluid. The blood flows through the uveal tissue and circulates into the ciliary 
bodies. The ultrafiltration of plasma penetrates through the fenestrations of the 
blood vessels. The ciliary body’s epithelium actively produces this filtered 
aqueous fluid. The blood flow rate (It is estimated to be 115 µl/min) to the 
ciliary body has been calculated indirectly by using the ascorbic acid level in 
the anterior chamber. The concentration of ascorbic acid in the aqueous is 20-
fold higher than plasma in humans. The ascorbic acid is not catalysed in humans 
due to the lack of enzyme required to break down ascorbic. Therefore, if the 
ratio of aqueous-plasma of ascorbic acid and the rate of aqueous humour 
formation rate is known, then one can calculate the minimal rate of blood flow 
to ciliary processes (Linner, 1951). If we apply the size of human pars plicata to 
animal studies of blood circulation to the ciliary bodies, the blood flow is 
measured at 154 µl/min. The rate of plasma filtration is about 2.7 µl/min 
(approximately 5% of plasma in the ciliary bodies). The main driving force for 
the aqueous formation is the oncotic pressure difference between blood vessels 
and the anterior chamber. This process is an active secretion. Aqueous humour 
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flow rate is at its peak in the morning due to adrenergic response and then it is 
reduced throughout the day, causing an IOP changes between 3-6 mmHg in 
normal eyes (Brubaker, 1991). This has been discussed earlier under section 
about changes of aqueous flow rate during sleep. 
The role of the aqueous humour is to nourish the intraocular structures; it brings 
antioxidants and maintains the firmness of the globe and intraocular pressure. 
The aqueous humour contains vitamin-C, nitric oxide (NOS), potassium and a 
trace amount of protein but that is close to zero. There is a fine balance between 
aqueous flow rate and outflow. Any disequilibrium would be disastrous to the 
ocular health. Too low outflow facility would lead to glaucoma. Too low of 
aqueous humour flow rate or too high of its drainage would cause hypotony. 
Both situations can ultimately lead to blindness. 
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Trabecular meshwork outflow 
 
The beam-like configuration of the trabecular meshwork (TM) structure 
comprises of trabecular meshwork cells surrounded by connective tissue sheets 
and beams. This structure connects the Schwalbe’s line to scleral spur and 
ciliary muscles and encircles the entire circumference of the anterior chamber 
angle recess (Carreon et al., 2017). Histologically, it can be split into three 
major parts: 
• The uveal meshwork 
• The corneoscleral meshwork 
• The juxtacanalicular (JCT) meshwork 
Direct micro-cannulation data have shown that the majority (90%) of resistance 
to outflow is between the anterior chamber and Schlemm’s canal. The 
remainder of resistance to flow is located between the canal and episcleral veins 
(Bill, 1993). Investigators have utilised electron microscopy to calculate the 
number of pores in the inner wall of the Schlemm’ canal. They have shown that 
there are approximately 20,000 pores in humans’ trabecular meshwork. The 
largest pores are measured 3µm. The trabecular meshwork cells have 
phagocytic ability which keep the TM free of debris (Johnson et al., 1989). 
Furthermore, TM cells play an active role in modulating the inflammation 
(Shifera et al., 2010) which has been harnessed in some glaucoma treatment 
modalities such as laser trabeculoplasty (Latina et al., 1998). Another function 
of the TM cells is to generate some resistance to the outflow. This is mediated 
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by fibroblastic and smooth muscle like function of the TM cells (Keller et al., 
2009). This feature enables TM cells to be contractile and with its counter-
tension, the ciliary muscle contracts to prevent the collapse of the 
trabecular-meshwork (Stamer and Clark, 2017). Mechanical stress from eye 
rubbing, blinking, eye movements, lack of blood supply and continuous 
exposure to free radicals from ultraviolet (UV) exposure, debris and waste 
within aqueous humour, pose a special challenge to TM cells. Therefore, several 
adaptive measures have been created within TM cells such as oxidative 
reducing materials (Russell and Johnson, 1996), special cytoskeleton (Baetz et 
al., 2009) and phagocytic ability (Sherwood and Richardson, 1988). Depending 
on the location of the TM cells their behaviour is more like the endothelium in 
the uveal/corneoscleral region and more fibroblast like in the juxtacanalicular 
region. Glaucoma (Grant, 1951; Stamer and Clark, 2017) and the ageing 
process– both reduce the trabecular outflow facility by increasing the outflow 
resistance (Toris et al., 1999). 
Another aspect of the trabecular meshwork which might be important in 
pathophysiology of raised IOP is trabecular meshwork stiffness. Last and 
associates (Last et al., 2011) assessed the compressive stiffness of the trabecular 
meshwork in glaucomatous eyes post-mortem. They showed that the stiffness of 
TM was much higher in glaucomatous eyes compared to the healthy eyes. Some 
observations in vivo and in vitro in human eyes showed that the extracellular 
matrix such as glycosaminoglycans (GAG) and proteoglycans are found 
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abundantly on the surface of the TM cells in the juxtacanalicular region. In 
perfusion studies using enzymes to degrade the extracellular matrix, increased 
trabecular outflow facility (Acott and Kelley, 2008). Additionally, it has been 
identified that in older eyes and in particular in glaucomatous eyes, there is a 
higher segmental flow (Buller and Johnson, 1994) and protrusion of 
extracellular matrix into the collector channels (Freddo and Gong, 2009). 
Over the past few decades, there have been several attempts to measure the 
aqueous humour parameters. The first tonometer was described by Makaklof in 
1885. Schiotz, Bock, Kronfeld, and Stough, and others all of whom observed 
that the ocular tension fell more slowly in glaucomatous eyes than in 
normal-eyes under the influence of the pressure after a tonometer was applied 
repeatedly at short intervals or after prolonged application (Scheie et al., 1956). 
The major milestone, however, was the introduction of tonography by Grant 
in-1950 (Grant, 1950). He published the result of a large study containing 
1000-tonography tracings in 1951 (Grant, 1951). 
Nowadays, there are indirect and direct methods of measuring trabecular 
outflow facility. With regards to indirect methods of measuring trabecular 
outflow facility, two main techniques have been developed. The conventional 
method of tonography is the weighted tonometer such as Schiøtz tonometer 
(Grant, 1950) or pneumatonometer (Langham et al., 1968). In these approaches, 
the extra weight of the tonometer causes a rise in IOP that disturbs the 
steady-state within aqueous humour dynamics akin to an exercise stress test. 
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The rate of recovery of IOP to its usual pressure is measured during 4-minute 
period while the tonometer remains on the eye (Brubaker, 2004). Later, Hayashi 
and colleagues in 1989 (Hayashi et al., 1989) introduced a method of measuring 
the trabecular-outflow facility whereby the aqueous flow was suppressed 
pharmacologically, and then the rate of aqueous flow rate reduction was 
measured afterwards. The difference between the pre- and post-medication of 
aqueous flow rate was calculated. This was then used as a proxy for trabecular 
outflow facility. 
Grant was the first to suggest Schiøtz tonography to measure the trabecular 
outflow facility. He spent many years on assessing the tonographic (trabecular) 
outflow facility of cadaveric eyes. He managed to refine his “weighted 
tonometry-technique” and finally, published his seminal paper in 1950 (Grant, 
1950). He measured the trabecular outflow facility via direct methods and 
compared them with the Schiøtz tonography (Grant, 1951). The result was 
comparable. The electronic Schiøtz tonography machine consists of a probe 
(houses a plunger) that indents the cornea and exerts force on the cornea. It 
artificially increases IOP. The tonography is a technique of measuring hydraulic 
resistance and postulates an indirect measure of trabecular aqueous outflow. 
This test is usually performed for 4-minutes in supine positions (Alaghband et 
al., 2018; Beltran-Agullo et al., 2011; Brubaker, 1975). As the time passes the 
plunger indents the cornea and the displacements of the plunger within the 
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probe creates an electrical current which in turn is transmitted to the 
galvanometer. Subsequently it moves the pen connected to the galvanometer to 
produce a tracing on the moving paper. Grant called this value “The coefficient 
of aqueous outflow facility” (C). 
The unit of tonographic outflow facility is µl/min/mmHg (microlitre of aqueous 
per millimetre of intraocular pressure per minute). This is essentially a 
quantitative illustration of how easily the fluid leaves the eye (the facility of 
outflow).  
In my projects in this thesis, I measured tonographic outflow facility (C) by a 
constant weight tonography (5.5, 7.5 or 10 g) using a modified digital 
Schiøtz-tonographer (designed by the Department of Bioengineering, Imperial 
College, London, UK) (Alaghband et al., 2019) at 10 – 11 AM (Figure 2-4). 
 
Figure 2-4 Schiøtz tonography machine 
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This device used an original Schiøtz tonographer footplate from a commercially 
available unit (model 720, Berkeley Bioengineering Inc., San Leandro, CA, 
USA) attached to a 3D printed shell that was designed such that the weight 
conformed to the specifications set out by the Committee on Standardization of 
Tonometers (Friedenwald, 1954)(Figure 2-5). 
 
Figure 2-5 The 3D printed shell for tonography machine 
Displacement of the weighted plunger was measured using a linear variable 
differential transformer (LVDT) (MHR series, TE Connectivity, Schaffhausen, 
CH, USA) driven by a signal conditioner (AD698, Analog Devices, Norwood, 
MA, USA) and captured digitally by a data acquisition system (USB-6009, 
National Instruments, Austen, TX, USA). Validation studies confirmed that the 
LVDT voltage output was linear with respect to the Schiøtz scale reading ( 
Figure 2-6), where each scale reading is equivalent to 0.05 mm of plunger 
displacement (Friedenwald, 1954). Using a micrometre, the plunger of 
the-LVDT was moved in increments of 50 µm, equivalent to 1 Schiøtz scale 
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reading, over the range of -1 to 20 scale readings, whilst measuring the LVDT 
voltage output ( 
Figure 2-6). Each position was measured 2 or 3 times, with all data shown. The 
voltage-displacement relationship was linear over the full range (R2 = 0.9997), 
allowing the measured LVDT voltage to be converted into a Schiøtz scale 
readings. A scale reading of -1 was defined as the reading when the footplate 
was placed on a rigid spherical surface with a 15 mm radius of curvature 
(Friedenwald, 1954). This is an original work which is already published as part 
of the aqueous humor dynamics in uveitic eyes project (Alaghband et al., 2019). 
 
Figure 2-6. Shows the correlation between digital and electronic Schiotz tonography. The grey cross 
represents the original Schiotz readings and the black cross shows the modified digital Schiotz 
tracings (R2 = 0.9997). 
,mmHg 
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Facility was estimated using Grant’s equation (Equation 2) (Grant, 1950). 
 
Equation 2 Shows the Grant's original equation 
𝐶 =
𝑉𝑐,𝑡 − 𝑉𝑐,0 +
1
𝐾 (𝑙𝑜𝑔 𝑃𝑡,0 − 𝑙𝑜𝑔𝑃𝑡,𝑡)
(
𝑃𝑡,0 + 𝑃𝑡,𝑡
2 − 𝑃0 − Δ𝑃𝑣)  𝑡
                              
Where 𝑉𝑐,𝑡 and 𝑉𝑐,0 are the aqueous volumes displaced at time 𝑡 and at the start 
of tonography (𝑡 = 0). 𝑃𝑡,𝑡 and 𝑃𝑡,0 are values of IOP at time 𝑡 and at the start of 
tonography. 𝑃0 is the IOP immediately prior to the start of the tonography. Δ𝑃𝑣 
is the change in episcleral venous pressure (EVP), assumed to be 1.25 mmHg 
(Leith, 1963). It is thought that the pressure applied on the eye during 
tonography can increase intra-orbital pressure and subsequently causing 
congestion of orbital veins and raised EVP. 𝐾 is the coefficient of ocular 
rigidity, assumed to be 0.0215/µl-1  (Friedenwald, 1948). The coefficient of 
ocular rigidity can be calculated using 𝑘 =
𝐿𝑜𝑔𝑃1−𝐿𝑜𝑔 𝑝2
𝑉1−𝑉2
, where V1 and V0 are 
the volumes indented in the eye by the tonometer when the pressure was P1 and 
P0, respectively. 𝑉𝑐,𝑡, 𝑉𝑐,0, 𝑃𝑡,𝑡, 𝑃𝑡,0 and 𝑃0 were determined based on the value 
of the Schiøtz scale reading and tables provided by Moses and Becker (Moses 
and Becker, 1958). By minimising the root mean square error between the 
tonographic tracing and Equation 1 the optimal value of 𝐶 was determined 
numerically. The black trace shows the captured signal from the LVDT, 
converted into Schiøtz scale readings (see Figure 2-6). The red line shows the 
predicted scale reading based on fitting Error! Reference source not found. to 
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the black tracing for the optimal value of C (in this case 0.31 µl/min/mmHg). 
Tonography was performed with a 5.5-gram weight placed on the right eye of a 
healthy volunteer (IOP = 16-mmHg) (Figure 2-7). The high frequency 
oscillations (~1 Hz) observed in the black tracing reflects the ocular pulse. 
 
Figure 2-7. A sample tracing of the digital Shiøtz tonography 
 
The recording Schiøtz tonometer I used in my studies had a concave tip with an 
external diameter of 10 mm. The total weight of the tip as applied to the cornea 
is 16.4 g (Figure 2-8). 
 
Figure 2-8 Close-up photo of the Schiotz tonography probe 
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Later Langham (Langham et al., 1968) suggested pneumatonography as a 
means to measure trabecular outflow facility. This device too has a probe which 
is supported by pneumatic force to indent the cornea (Figure 2-9). 
 
Figure 2-9 Close-up photo of pneumatonography probe 
The total weight of the Schiøtz and pneumatonometer probes are similar (16.4 g 
and 14.7 g respectively), the difference in tip sizes; However, the concave base 
of the probe in Schiøtz is 10 mm vs. 5.3-mm in radius with a flat tip of 
pneumatonometer. This results in a 4-fold larger surface area for the Schiøtz tip; 
therefore, the smaller pneumatonometer tip can lead to a greater application of 
pressure (Lim et al., 2008). This could cause physical changes to the aqueous 
humour outflow system. Also, there is a larger intraobserver and inter-subject 
variability (Lim et al., 2008; Feghali et al., 1986). In a laboratory based study, 
Moses (Moses, 1967) commented that pneumatonography is unsuitable for the 
assessment of outflow facility because it underestimates the magnitude of 
changes in IOP, and the additional 10-g weight required for tonography causes 
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the scale reading to underestimate IOP readings during tonography. This may 
well be due to the greater mobility of the pneumatonometer probe on the 
corneal surface and the greater transmission of subject’s head movements and 
the operator’s hand tremor to the device. There is a guide ring around Schiøtz 
probe which dampens the transmission of any unwanted movement to the 
transducer. The debate over reliability of these two methods is eloquently 
discussed in Kazemi et al. paper (Kazemi et al., 2017). They compared two 
methods in 56 eyes of 28 participants. They found that there is a tendency for 
higher tonographic outflow facility readings by using Schiøtz tonography as 
opposed to pneumatonography. However, they calculated the scleral rigidity 
(Moses and Becker, 1958) for each participant and once they adjusted it for the 
tonographic outflow facility readings, both techniques were equally reliable; 
however, they suggested that the use of each method is not interchangeable. 
Both devices, Schiøtz tonography and pneumatonography, measure the decay of 
the acutely elevated IOP and assume aqueous flow rate changes are minimal 
during this time (Garner, 1965). The assumption is that the changes in IOP is 
only due to increased trabecular outflow facility during the tonography whilst 
aqueous flow rate (as a proxy of aqueous production) remains unchanged. The 
Schiøtz tonography has a standard weight of 5.5g for IOP below 20 mmHg, 
then 7.5g is used for 20-30 mmHg and finally, 10g for IOP >30 mmHg (Garner, 
1965). The comparison for different trabecular outflow facility measurement 














unchanged Pressure is reduced 
(halved the baseline) 
Pressure increased 
twice the baseline 
Test duration 4 minutes 4 hours 3 hours  4-minutes, 2-minutes 
Ocular tissue 
volume 
Indentation of cornea 
and expansion and 
contraction of sclera 
unchanged Sclera may contract 
but this change is 
negligible 
Indentation of cornea 
and expansion and 
contraction of sclera 
Aqueous flow May alter slightly 
(pseudo-facility of 
Barany is within the 
assumption) 
Unchanged The flow is reduced 
in second part of the 
test 
May alter slightly 
(pseudo-facility of 




Assumed to rise 
1.25-mmHg 













Not applicable Fluorescein Aqueous suppressants i.e. 





Not applicable  Does not change the 
aqueous parameters 





Assumed to be 
stable during 
measurement and 
not affected by 
IOP 
Assumed to be 
stable during 
measurement and 
not affected by IOP 
Assumed to be stable 
during measurement 
and not affected by 
IOP 
Assumed to be stable 
during measurement 
and not affected by 
IOP 
Table 2-1. Comparison between existing methods of measuring human facility of outflow 
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Several assumptions have to be met in order to have a reliable tonography 
measurement. Indentation tonography makes no compensation for the 
individual variations in ocular rigidity. The stiffer the eye, the greater force 
required to indent the cornea and displace the aqueous humour. Nonetheless, the 
scleral rigidity coefficiency is assumed to be an average of 0.0215µL-1 
(Friedenwald, 1954). Moreover, this figure is normally derived from cadaveric 
eyes for Schiøtz-tonography and in pneumatonography from living eyes (this is 
one of the shortcomings of Schiøtz tonography). Another assumption is that 
cornea is a perfect sphere. 
Other assumptions are listed below (Drance and Carr, 1960; Feghali et al., 
1986). 
• The tonography is accurately calibrated 
• Corneal flexibility is negligible 
• The amount of fluid displaced during measurement is accurately known 
• Scleral elasticity is known 
• Ocular blood and tissue volume remain unchanged 
• Aqueous humour flow rate (as a proxy of aqueous humour production) 
remains constant and not affected by IOP 
• Episcleral venous pressure remains unchanged during tonogrpahy 
• Intraocular fluid change is solely due to indentation of tonography 
• The duration of test is long enough for the rate of IOP to decay 
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• The eye is in the steady state 
• Pseudofacility is negligible 
At the present time, tonography is the best available method measuring the 
trabecular outflow facility. In an experiment, Becker and Constant (Becker and 
Constant, 1956), performed tonography in-vivo and in vitro with perfusion 
methods of measurement of the outflow facility. They used 28 rabbit eyes and 
four human eyes which were due to be enucleated. They found good correlation 
between direct and indirect methods. They concluded that tonography is a 
reliable and accurate technique of measuring the trabecular outflow facility. 
It has been known for a long time that compressing or contusing one eye can 
affect the other eye’s IOP consensually (ophthalmotonic-consensual reaction). 
Barany and Wirth (Barany and Wirth, 1954), noticed that performing 
paracentesis in one rabbit’s eye, can reduce the aqueous flow rate of the fellow 
eye. Other investigators (Prijot and Stone, 1956) noted that when one eye was 
compressed, the tonogram of the fellow eye became flat. Prijot and Stone (Prijot 
and Stone, 1956), applied compression on one rabbit’s eye and observed 
reduction of IOP and aqueous flow rate of the fellow eye. This phenomenon is 
called “ophthalmotonic consensual reaction”. The term was first coined by 
Weekers in 1924 (Weekers, 1924). Cambiaggi and Spurgen (Cambiaggi and 
Spurgeon, 1959), studied tonographic changes in a group of 16-healthy 
volunteers eyes and 24 glaucomatous eyes. They performed 
electronic-tonography on two separate days. On day one, tonography was first 
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performed on the right eye of each case followed by 4-minute intervals and then 
tonography of the left eye. On the second day, the order of measurement was 
reversed i.e. left eye first and then right eye and there was 2-minute interval 
between the two measurements. They demonstrated that the difference between 
the two eyes were not statistically significant. Although, the mean IOP of the 
second eye after initial tonography was slightly lower, it was not statistically 
significant. This change has been ascribed to the “vascular reflex”. In this 
theory, it is suggested that the neural inputs may affect the episcleral venous 
pressure in both eyes during tonography. However, there is no strong evidence 
for this phenomenon (Leith, 1963). Nevertheless, the mean tonographic outflow 
facility measurement did not alter in either eye by tonography of the fellow eye 
when there is sufficient interval between each measurement. However, Grant 
and English (Grant and English, 1963) have shown that if the fellow eye is 
covered by something such as cling film to reduce the rate of evaporation of the 
tear, the chance of desiccation of the fellow eye would be minimised. Therefore, 
it is thought that tonography may change the ocular hydrodynamics (including 
hysteresis) only transiently. 
Spencer et al. (Spencer et al., 1955) performed repeated tonography in 
14-normal eyes to assess the repeatability of the test. They found that the 
average variation was ±0.045-µl/min/mmHg (19%) between the same eye of 
each participant. They demonstrated no diurnal variation. Additionally, they 
repeated the measurements on several days at different times of the day. 
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The mean variation was ±0.053-µl/min/mmHg (25%). They noted that the 
variability of the measurement was less if the tonography was performed at the 
same time of the day rather than at different time of the successive days. 
Tonography is subject to some errors. Potential sources of error can be 
categorised as instrument, eye, patient and operator related. 
• Instrument: error in design and manufacturing of the instrument 
• Eye: variations of the corneal curvature, biomechanics and ocular rigidity 
• Patient: fluctuations in systemic blood pressure, cardiac arrhythmias, 
exophthalmos, changes in breathing rate, coughing, Valsalva manoeuvre, 
contractions of extraocular muscles, removing tight tie or collar 
• Operator: distraction and inattention to the position of the probe on the 
eye, anxiety of the operator and hand tremor, mislabelling of tracings and 
not enough retraction of eyelids 
 
The normal value for the tonographic outflow facility ranges between 
0.2-0.4-µl/min/mmHg. The cut off point for an abnormal tracing to signify a 
compromise in outflow facility is <0.2-µl/min/mmHg (Lim et al., 2008; 
Beltran-Agullo et al., 2011). 
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Episcleral venous pressure 
 
Friedrich Schlemms (Leber, 1895) discovered the Schlemm’s canal and Karl 
Ascher (Ascher, 1949) described the aqueous veins later in the 20th century. He 
suggested that episcleral veins are connected to the Schlemm’s canal. He 
observed that the aqueous humour flows through Schlemm’s canal and enters 
collector channels and drains into episcleral veins. Mixture of blood vessels 
(arteries and veins) make up the episcleral vasculature. At present, it is not 
clearly known how the episcleral veins are regulated. Grant and many other 
investigators have suggested that the majority of resistance to the outflow of 
aqueous humour is located at the distal section of Schlemm’s canal (Grant et al., 
1958). One possible explanation of this resistance may well be due to the 
special structure of the collector channels and episcleral veins. Recent studies 
by Johnston et al. have shown that the flow within the collector channels are 
controlled by a series of hinges and valves which can create further resistance to 
the aqueous flow (Johnstone et al., 2016). Goldmann (Goldmann, 1951) 
described a method of measuring episcleral venous pressure (EVP) by applying 
a constant pressure over the conjunctiva and look for blanching of the vessels. 
Then Linner (Linner, 1958), used a known force over the eye through a 
transparent distensible membrane. In this method, collapse of blood vessels 
were the endpoint of the measurements. Others have used direct cannulation of 
the episcleral veins to measure EVP. Brubaker et al. (Brubaker, 1967) compared 
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the torsion balance method (similar to Goldmann’s technique), pressure 
chamber method and direct cannulation method. They concluded that even 
though the results of the measurements from each method were comparable, the 
direct cannulation method showed the least variability. In addition, the direct 
cannulation is based on fewer assumptions. In another study, Lim et al. (Lim et 
al., 2008) utilised an episcleral venomanometer (pressure chamber method) to 
measure EVP. In this method the balloon membrane was placed on the eye, 
close to a large scleral vessel. Under direct visualisation, the dial on the 
instrument is turned to increase the pressure within the balloon to collapse the 
vein. The endpoint was that the blood vessel to collapse half of its original 
diameter (half-blanched). The measurement value varied widely between 
participants and among the fellow eyes of the same participants and also with 
the measurements of the same eye of the same participant (few-minutes apart). 
Interestingly, the Valsalva manoeuvre did not affect the readings. They 
concluded that the measurement from this instrument was very inconsistent. 
The suggestion is to use the assumed value of 10 mmHg for EVP 
measurements. Sit and associates (Sit et al., 2011) developed a computerised 
venomanometry to measure episcleral venous pressure in a non-invasive 
manner. It improves the accuracy of identifying the compression of veins 
endpoint objectively. This technique was based on the pressure chamber method 
too. The device consists of a camera that captures the images of the episcleral 
vessels, a computer-controlled motor drives the pressure adjustments and 
 53 
pressure transducer. This method was utilised in five healthy subjects’ eyes to 
measure EVP. On average, EVP was 6.3 mmHg in healthy individuals using Sit 
et al. technique (however, the range can vary due to inherent 
variability/inaccuracy of the technique). Their measurements were constant 
between subjects. It is assumed that the variabilities in the EPV measurement 
arise from the lack of unanimity in identifying clear endpoints of the vascular 
collapse. Additionally, no comparison has been made between the direct 
methods to validate the result of Sit et al. technique. Nevertheless, it is the most 
objective yet indirect method of measuring episcleral venous pressure. The 
average EVP in the upright position varies between 7.6 and 11.4 mmHg 
depending on different studies. Interestingly, in studies on Sturge-Weber 
syndrome (Phelps and Armaly, 1978) which is believed that EVP to be high, the 
episcleral venous pressure measurements varied significantly. This again 
reiterates the uncertainties in the endpoint determination of blood vessels 
collapse. Alpha adrenergics appear to reduce episcleral venous pressure (C. 
Toris et al., 1995). However, the evidence is controversial, and some other 
studies did not show any significant change in EVP (C. B. Toris et al., 1995). 
New generation of glaucoma medications including rho kinase inhibitors 
(ROCK) are shown to reduce the episcleral venous pressure (Wang et al., 2015; 
Kazemi et al., 2018). Although, the EVP measurement (whether direct or 
indirect) has a great variability, the subjectivity in direct methods are 
considerably smaller compared with indirect methods (Brubaker, 1967). 
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However, indirect methods are the only available techniques to measure 
episcleral venous pressure in humans at present. In this thesis I have used the 





Leber (Leber, 1895) demonstrated that after the injection of a tracer into the 
anterior chamber, most of it goes through the trabecular meshwork but some of 
it was found to be in the supra-choroidal space. Other studies which followed 
on afterwards, showed the tracer in areas such as sclera, and choroid. Fine 
(Fine, 1964) concluded that there must be an unconventional pathway of 
aqueous outflow. It was not until 1965 that Bill (Bill, 1965) set the foundations 
of our understanding of unconventional outflow pathways. This was a turning 
point in the history of aqueous humour dynamics. Now having equipped with 
the new knowledge of unconventional pathways, the imbalance of the 
Goldmann equation could be accounted for. Bill (Bill, 1965) perfused anterior 
chamber of monkey eyes with labelled tracers and observed different areas that 
the tracer exited from the eye. He showed that a significant percentage of 
aqueous humour drainage bypassed the trabeculum (about 20%) and the 
remainder of the tracer was found in the choroid, sclera and ciliary bodies. From 
there, the fluid either was absorbed into the choroidal circulation or seeped 
through the sclera into the orbital tissues. Bill referred to this pathway as the 
‘unconventional’ pathway to differentiate it from “conventional” trabecular 
outflow. Now this definition has expanded to include corneal, iris and retinal 
pathways too. Bill in 1977 (Bill, 1977) illustrated that the iris and corneal route 
are insignificant. If retina remained attached, the pumping mechanism of the 
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retinal pigment epithelium which is the driving force for the retinal flow of 
aqueous humour, is minute. Bill in his animal experiments showed that the flow 
of aqueous humour via unconventional pathway is not dependent on IOP and it 
accounts for 20% of the aqueous outflow. The aqueous enters the uveal tract 
and then through ciliary bodies and then gains access to supra-choroidal space. 
However, there is much debate about what is the fate of this part of aqueous 
humour from here. Some suggested that it will dissipate into the orbital tissues 
and absorbed. Others have proposed that it drains through the vortex veins 
(uveo--vortex outflow). More recently, some investigators have proposed that 
this fluid may drain into the ciliary lymphatics (uveo-lymphatic pathways). 
Unconventional outflow, regardless of which pathway it is passing through 
(uveo-scleral, uveo-vortex or uveo-lymphatic), it should cross the ciliary body 
tissue (Johnson et al., 2017). It is difficult to measure the rate of the 
unconventional outflow quantitatively. Additionally due to diffused flow pattern 
of the unconventional outflow, it is challenging to pursue its path accurately. 
Nonetheless, two methods have been described, either direct measurements by 
utilising labelled tracers or indirect methods. The former is the gold standard, 
but it is invasive and not ethical for humans (due to the risk of radiation). In 
indirect methods, unconventional flow is calculated by deduction from the 
difference between the aqueous humour flow rate and trabecular (tonographic) 
outflow facility using a modified version of the Goldmann equation. However, 
the result of this method is varied considerably and does not match the values of 
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unconventional outflow derived from the direct measurement techniques. 
Overall, the indirect method over-estimates the unconventional outflow. The 
main issue of using the indirect-method is, the calculation is subject to many 
assumptions. Furthermore, the Goldmann equation is based on the assumption 
that trabecular (tonographic) outflow and episcleral venous pressure are 
independent of IOP. 
In the living eye, uveoscleral and uveo-vortex pathways both contribute to 
unconventional outflow. Therefore, using the term uveoscleral outflow (extra-
trabecular pathway) would be confusing. Johnson et al. (Johnson et al., 2017) 
suggested the term non-trabecular outflow as a more representative of the 
description; however, some investigators resorted to unconventional outflow 
which is more acceptable. I have used uveoscleral outflow term in the rest of 
this thesis.  








Pressure sensitivity Pressure dependent Pressure-independent (between 4-
35 mmHg) 
Proportion of outflow 80% 20% 
Influence of ciliary 
muscle contraction 
after application of 
pilocarpine 
minimal Controls most of flow 
(approximately 90%) 
Difference between 
living and post-mortem 
tissue 
same Increased significantly after death 
(due to loss of ciliary muscles tone) 
Flow rate 0.2-0.4 µl/min/mmHg 0.4–0.6 µl/min 
Effect of aging Aging reduces the outflow Aging reduces the outflow 
Glaucoma Decreased flow Decreased flow 
Main area of resistance Trabecular meshwork, 
Schlemm’s canal and 
episcleral veins 
Ciliary bodies 
Table 2-2. Comparison between conventional and unconventional outflow pathways 
 
In the modified Goldmann equation, the unconventional outflow (U) is regarded 
as a constant that can be altered according to changes in IOP. However, 
unconventional outflow pathway is pressure independent. Hence, including 
driving forces of unconventional pathways and the pseudo-facility (Moses et al., 
1985), would enhance the aqueous humour dynamics model. Interestingly, 
when ciliary body is removed such as in cyclodialysis cleft, the unconventional 
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outflow resistance would be circumvented. The unconventional outflow would 
then increase significantly and becomes pressure dependent. 
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Aqueous humour dynamics measurement methods used in this thesis 
 
Aqueous flow rate measurement 
The night before (10 PM) the fluorophotometric scans, participants self-
administer from 3 to 5 drops of fluorescein sodium 2% (Minims; Bausch & 
Lomb, Kingston-upon-Thames, UK) topically into both eyes at 5-minute 
intervals depending on their ages (age < 26 years, 5 drops; age 26–35 years, 4 
drops; >35 years of age, 3 drops) (Brubaker et al., 2001). Fluorophotometry is 
performed in both eyes with a scanning ocular fluorophotometer (FM-2, 
Fluorotron Master ocular fluorophotometer; OcuMetrics, Mountain View, CA) 
from 9 AM to 12 noon. The aqueous flow rate is determined using dedicated 
software provided with the fluorophotometer. Triplicate scans are collected and 
repeated at 1-hour intervals for four measurements to determine the aqueous 
humour flow rate (Ff). Following each set of scans, IOP is measured using 
pneumatonometry (Model 30 Classic; Reichert Ophthalmic Instruments, 
Depew, NY); IOP is recorded as the arithmetic mean of a total of 12 
measurements per eye (3 measurements every hour alternating between eyes). 
Tonographic outflow facility measurement 
Tonographic outflow facility (C) is measured by constant weight tonography 
(5.5. 7.5 or 10 g) using a modified digital Schiøtz tonographer (designed by the 
Department of Bioengineering, Imperial College, London, UK) at 10 – 11 AM. 
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It is assumed that tonographic outflow facility is the measured trabecular 
outflow facility. In this device I used an original Schiøtz tonographer footplate 
from a commercially available unit (model 720, Berkeley Bioengineering Inc., 
San Leandro, CA, USA) attached to a 3D printed shell that was designed such 
that the weight conformed to the specifications set out by the Committee on 
Standardization of Tonometers (Friedenwald, 1954). Displacement of the 
weighted plunger was measured using a linear variable differential transformer 
(LVDT; MHR series, TE Connectivity, Schaffhausen, CH, USA) driven by a 
signal conditioner (AD698, Analog Devices, Norwood, MA, USA) and 
captured digitally by a data acquisition system (USB-6009, National 
Instruments, Austen, TX, USA). Validation studies confirmed that the LVDT 
voltage output was linear with respect to the Schiøtz scale reading (Figure 4-2), 
where each scale reading is equivalent to 0.05 mm of plunger displacement 
(Friedenwald, 1954). Facility was estimated using Grant’s equation (Equation 
2) (Grant, 1950). 
𝐶 =
𝑉𝑐,𝑡 − 𝑉𝑐,0 +
1
𝐾 (𝑙𝑜𝑔 𝑃𝑡,0 − 𝑙𝑜𝑔𝑃𝑡,𝑡)
(
𝑃𝑡,0 + 𝑃𝑡,𝑡
2 − 𝑃0 − Δ𝑃𝑣)  𝑡
          𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2 
where 𝑉𝑐,𝑡 and 𝑉𝑐,0 are the aqueous volumes displaced at time 𝑡 and at the start 
of tonography (𝑡 = 0). 𝑃𝑡,𝑡 and 𝑃𝑡,0 are values of IOP at time 𝑡 and at the start of 
tonography. 𝑃0 is the IOP immediately prior to the start of tonography. Δ𝑃𝑣 is 
the change in episcleral venous pressure, assumed to be 1.25 mmHg 
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(Friedenwald, 1948), and 𝐾 is the coefficient of ocular rigidity, assumed to be 
0.0215/µl-1  (Moses and Becker, 1958). 𝑉𝑐,𝑡, 𝑉𝑐,0, 𝑃𝑡,𝑡 , 𝑃𝑡,0 and 𝑃0 were 
determined based on the value of the Schiøtz scale reading and tables provided 
by Moses and Becker (Moses and Becker, 1958). By minimising the root mean 
square error between the tonographic tracing ( 
Figure 4-3) and Equation 1 , the optimal value of 𝐶 was determined numerically. 
Uveoscleral outflow measurement 
At present clinical measurement of the uveoscleral outflow in humans is not 
possible (Johnson et al., 2017); hence this value is generally calculated from the 
Goldmann’s equation. Sit and McLaren used a computerized venomanometry to 
measure episcleral venous pressure (EVP) (Sit and McLaren, 2011; Brubaker, 
1967). They illustrated that EVP in normal subjects can vary between 6 and 
10-mmHg. Therefore, I have used 10 mmHg for our calculations. 
Uveoscleral outflow was calculated using Goldmann’s equation (Equation 3) 
with an assumed episcleral venous pressure of 10 mmHg. 
𝐹𝑓 =  (𝑃𝑖 − 𝑃𝑒)𝐶 +  𝐹𝑢                    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 3  
“Ff” is the rate of aqueous humour formation measured by fluorophotometry, 
“C “is the tonographic facility of outflow, “Pi” is the intraocular pressure, “Pe” 
is the episcleral venous pressure, and “Fu” is uveoscleral flow. 
Therefore, 
    𝐹𝑢 = 𝐹𝑓 − 𝐶(𝑃𝑖 − 𝑃𝑒)   
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Only one randomly (Excel random number generator; Microsoft, Redmond, 
WA) chosen eye per participant was included in the data analysis, when both 
eyes fulfilled the inclusion criteria. 
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Chapter 3|The effect of phacoemulsification on outflow facility 
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This chapter is presented as a published paper. 
 
Pouya Alaghband , Laura Beltran-Agulló, Elizabeth A Galvis, et al Effect of 




Several studies explored the effects of phacoemulsification on intraocular 
pressure (IOP) changes at short (6 months), medium (36 months) and long term 
(60 months) (Merkur et al., 2001; Mathalone et al., 2005; Peräsalo, 1997; 
Shingleton et al., 2006; Mansberger et al., 2012). The reported IOP reduction 
varies between 1.5 and 9.0 mmHg (Slabaugh et al., 2014; Mansberger et al., 
2012; Pfeiffer et al., 2015). Different mechanisms of action have been proposed 
for the IOP lowering effects following cataract surgery, including the 
mechanical influence of the lens removal (Slabaugh et al., 2014), increased 
uveoscleral outflow, and increased trabecular outflow (Dooley et al., 2010). 
However, there are no studies using electronic Schiøtz tonography assessing the 
effect of modern small incision phacoemulsification with intraocular lens 
implantation on tonographic outflow facility. 
Lee and Trotter (Lee and Trotter, 1957) investigated the effect of extracapsular 
cataract extraction without intraocular lens implantation on the facility of 
outflow. They used electronic Schiøtz tonography in patients with cataract of 
whom seven cases had open or closed angle glaucoma and 11 cases of 
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pseudoexfoliation. They showed that facility of outflow decreased within first 3 
weeks postoperatively but then returned to preoperative values within 4 months 
after the operation. However, in this study outflow facility changes were very 
variable. Additionally, they had included mixed cases of complicated surgeries 
such as vitreous loss and the follow-up was only 6 months. 
Another study by Meyer and associates (Meyer et al., 1997), demonstrated that 
pneumatonographic outflow facility after phacoemulsification improved on the 
first day after surgery; however, outflow facility at 1 year 
(0.46±0.38-µl/min/mmHg) was not statistically different compared to the 
baseline of 0.39±0.23 µl/min/mmHg. 
To date there have been no studies using electronic Schiøtz tonography (which 
is a method of outflow facility measurement with less inter-subject and inter-
observer variability compared to pneumatonography (Lim et al., 2008; Grant, 
1951; Feghali et al., 1986)) to determine the effect of modern small incision 
phacoemulsification cataract surgery on tonographic facility of outflow. 
Materials and Methods 
 
Ethics approval for this study was obtained from the St. Thomas’ Hospital local 
research ethics committee. This research conformed to tenets of the Declaration 
of Helsinki. Patients with visually significant cataract with primary open angle 
glaucoma (POAG) or cataract with otherwise healthy optic disc and no 
diagnosis of glaucoma, who were due to undergo phacoemulsification with 
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intraocular lens implantation, were enrolled in this prospective study. The 
POAG cases did not have washout from their hypotensive medications prior to 
the study measurements. The recruitment took place between September 2009 
and May 2011. POAG was defined as raised IOP on at least one occasion and 
abnormal visual field testing with corresponding optic disc changes (patients 
with normal tension glaucoma were not included in this study). Only one eye 
per patient was included in the final analysis (all measurements were performed 
on both eyes). When both eyes were eligible, only the first eye to be operated on 
was included in the analysis (the alternative method would have been to include 
both eyes and use between the two-eye correlation). Patients were provided with 
study information at the initial contact, and signed informed consent was sought 
before measurements and the surgery. Patients with any previous history of 
intraocular or keratorefractive surgery, normal tension glaucoma, any secondary 
glaucoma including traumatic, neovascular, uveitic, pseudoexfoliative and 
pigment dispersion syndrome were excluded. 
 
Contralateral eyes of the study patients, which did not undergo any intraocular 
surgery during the follow up period, with available tonographic outflow facility 






All patients underwent a comprehensive ophthalmic examination before the 
operation; including visual acuity measurement (LogMAR), slit lamp 
biomicroscopy, gonioscopy (using 2-mirror magnaview goniolens, Ocular Inc., 
WA, USA), intraocular pressure (IOP) measurement using Goldmann’s 
applanation tonometer, anterior chamber depth (ACD) and axial length (AXL) 
measurement using IOL Master (Carl Zeiss Meditec Inc., Dublin, CA), central 
corneal thickness (CCT; Pachmate DGH 55, DGH Technology, Inc., Exton, 
PA), static automated visual field (Humphrey automated white-on white, 24-2 
SITA-standard; Carl Zeiss Meditec), and dilated ophthalmoscopic examination. 
Tonographic outflow facility (TOF = “C”) was measured with an electronic 
Schiøtz tonographer (model 720; Berkeley Bioengineering Inc., San Leandro, 
CA) on the day of the surgery (between 9 and 11 am) prior to the operation and 
then repeated at 3, 6 and 12 months postoperatively. The facility of outflow was 
measured from the rate of the decay of IOP in the supine position during 
application of a recording Schiøtz tonometer probe on the cornea, over a period 
of 4 minutes with a standard 5.5-g weight (Grant, 1951). Nine readings at 30-
second intervals were manually entered the McLaren tonography computer 
program (Lim et al., 2008). The program fits a second-degree polynomial by the 
method of least squares to nine data points and determines by extrapolation, the 
best-fit values at time 0 and 4 minutes. The values at 0 and 4 minutes are then 




Cataract surgery was performed by an experienced surgeon (KSL) under local 
or general anaesthesia. A clear corneal incision (2.8 mm) was made and 
followed by a paracentesis and the injection of viscoelastic. Then capsulorrhexis 
and hydro-dissection was performed. The lens was removed by 
phacoemulsification of the lens nucleus and aspiration of the cortical lens 
matter. After further injection of the viscoelastic, an acrylic injectable 
intraocular lens (AcrySof SA60AT, Alcon, Texas, USA) of the appropriate 
power was inserted into the capsular bag. The viscoelastic was washed out and 
an intracameral antibiotic injection was given at the end. Patients received 
Maxitrol® (Neomycin sulphate 3500 IU/ml, Polymyxin B sulphate 6000 IU/ml 
and 1 mg Dexamethasone, Alcon lab., UK) four times daily for two weeks and 
then twice daily for another two weeks postoperatively. All patients were off 
steroid treatment after this period. 
Data Collection and Outcome Measures 
 
Data including age, gender, race, IOP, TOF, CCT, axial length, anterior 
chamber depth, gonioscopy, vertical cup: disc ratio, and mean deviation in 
visual field testing were recorded. 




Sample size calculation 
This study had a 90% chance of finding a 5% difference in IOP, and 7.5% 
difference in outflow facility if these differences existed (n=30 subjects, 
alpha-0.05, and beta 0.10). This is assuming that the baseline IOP and TOF is 
similar in POAG and cataract only groups. However, the current study was 





Student’s paired t-test and one-way analysis of variance for repeated measures 
(ANOVA) were used to compare continuous variables among groups. The 95% 
confidence intervals (CI) for the mean difference between pairs for each 
outcome measure were calculated. Linear regression analysis was used to 
determine the correlation between IOP, facility of outflow, and difference from 
baseline. P <0.05 was considered to be significant (IBM SPSS. V23.0, IL, 
Chicago, USA). 
Results 
Forty-one patients were enrolled in the study. Eight patients withdrew after 
signing the consent, due to their time constraints and inability to attend all 
required post-operative visits. Three subjects had poor tonography tracings on at 
least one time point (10% rejection rate in aqueous humour dynamic 
measurement is similar to previous studies) (Lim et al., 2008). One case was 
 71 
excluded due to an intraoperative complication (posterior capsular rupture and 
vitreous loss) and two further cases were omitted due to persistent post-op 
uveitis. In total, data from 27 patients with reliable tonographic outflow tracings 
at baseline and all subsequent study visits, were included in the final analysis. 
Only one eye from each patient was used for the analysis. 
 
Sixteen individuals had cataract only, whilst 11 cases had an existing diagnosis 
of POAG. The average age was older in POAG group but the difference was not 
statistically significant (in cataract cases mean age was 67±11.2 years, while in 
POAG group it was 73±7.2 years, p=0.09). Other baseline characteristics of 
each group is shown in Table 3-3 
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Table 3-3. Baseline characteristics. IOP: intraocular pressure, ACD: anterior chamber depth, AXL: 
axial length, CCT: central corneal thickness, BCVA: best corrected visual acuity, HVF: Humphrey 
visual field. * statistically significant, †Student paired t test (two sided), ‡ Mann Whitney U test 
 Cataract only 
(n=16) 
POAG and cataract 
(n=11) 













0.09 -14.8-1.1 -0.66 69±10.2  
(43-83) 
Gender (F:M) ‡ 9:7 3:8 0.4 --- --- 12:15 



























0.5 -29.4-14.1 -0.28 538±26 
 (497 – 596) 
Mean IOP  





0.7 -3.50 – 2.4 -0.16 15.9±3.66  
(10-26) 






0.4 -0.03–0.08 0.33 0.14±0.06 
(0.04– 0.29) 
Median HVF  





<0.001* ---- --- -3.1±8.84  
(-14 - 3) 




<0.001* ---- --- 0.5  
(0.2-0.9) 






0.06 -2.1-9.9 0.52 18.2±7.5  
(10 – 31) 






0.16 -1.8-3.3 0.24 1.9±3.13  
(0.5 – 3.4) 
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Baseline IOP was similar in each group (15.7±2.7mmHg in non-glaucomatous 
cases vs 16.3±4.8 mmHg in POAG with cataract group, p=0.7, 95% CI:-3.6–
-2.4). Cases with POAG did not have washout from their hypotensive 
medications. 
Overall, IOP reduced by 2.0±3.2 mmHg at 3 months (12% decrease), while at 6 
and 12-month visits, it only reduced by 1.7±3.4 (10% decrease) and 2.0±3.6 
mmHg (10% decrease) respectively (Table 3-4 & Figure 3-1). We used one-
-way-ANOVA for repeated measures to compare IOP between each visit. The 
IOP reduction at all post-op visits was statistically significant (3 months 
p=0.003, 6 months p= 0.04- and 12-months p= 0.02). 
 
Table 3-4. This table illustrates IOP reduction at post op visits at 3, 6 and 12 months 
compared with baseline IOP. Additionally, percentage of IOP reduction is shown. 
 IOP at baseline, 
mmHg 
IOP at 3m mmHg, 
% of reduction 
IOP at 6m mmHg, 
% of reduction 
IOP at 12m mmHg, 





14.4±2.6*, (7%) 13.7±2.9*, (12%) 
POAG group 
(n=11) 





14.3±3.0*, (10%) 13.9±3.2*, (10%) 
* statistically significant 
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Figure 3-1 Shows intraocular changes at different time points 
 
TOF improved significantly at all post-op time points after cataract extraction 
compared to the baseline ( 
 
Figure 3-2 and   
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Table 3-5). However, TOF enhancement did not differ between each visit using 
one-way ANOVA for repeated measures (at 3 months p=0.7, at 6 months p=0.4 
and at 12 months p=0.2). There was no statistically significant correlation 
between phaco power and TOF at any time point (at 3 months p=0.5, at 6 
months p=0.4 and at 12 months p=0.7). 
 




Table 3-5. This shows TOF enhancement post-surgery at each post op visit at 3, 6 and 12 months 
compared with baseline TOF. Additionally, the percentage of TOF enhancement is shown  
 TOF at baseline, 
µl/min. mmHg 
TOF at 3m (µl/min. mmHg), 
% of enhancement 
TOF at 6m (µl/min. mmHg), 
% of enhancement 
TOF at 12 (µl/min. mmHg), 










0.13±0.08 0.15±0.06 (14%) 0.17±0.07* (16%) 0.17±0.08 (15%) 
Overall 
(n=27) 
0.14±0.06 0.18±0.08* (16%) 0.20±0.09* (15%) 0.17±0.08* (10%) 
* statistically significant 
The average post-op IOP in cataract and POAG cases are shown in Table 3-4 
and  
Figure 3-3. Mean IOP in cataract cases at 12 months’ post-surgery was 
13.7±3.0-mmHg; this was comparable to POAG cases in which IOP decreased 
to 14.2±3.7-mmHg (p=0.7, 95% CI: -3.0 – 2.2). Overall, baseline IOP was a 
moderate predictor of post-operative IOP reduction at all time points (p=0.004, 
r=0.53). 
 
Figure 3-3. Intraocular pressure changes over 12 months’ period compared between each visit. * 
statistically significant. (The vertical bars represent range; the boxes outer border shows the 





Additionally, there was no statistically significant correlation between TOF 
changes and IOP alterations at 12 months (p=0.08, r2=0.1) (Figure 3-4). 
Furthermore, there was no statistically significant correlation between AXL and 
ACD with IOP and TOF (p=0.9, r2=0.002). 
 
Figure 3-4. shows Spearman correlation between TOF changes and IOP alterations at 12 months. 
There is no linear correlation (p=0.08, r2=0.1) 
 
 
The number of glaucoma medication and treatment regime remained unchanged 
in the POAG group at baseline and at all post-operative visits. All patients were 
TOF improvement at 12 months (difference between baseline and 12 months visit)






























































on prostaglandin analogues. Additionally, five patients were taking beta 
blockers, four patients carbonic anhydrase inhibitor and one patient was on 
alpha-2 agonist medications.  
The IOP reduction was statistically significant at all post-op visits in cataract 
groups but not in the POAG group ( 
Figure 3-3 and Table 3-4).  
Whilst TOF in cataract group only improved at 3 and 6 months post operatively, 
in the glaucoma group only month 6 TOF enhancement was statistically 
significant. The comparative data are presented in Figure 3-5. 
 
Figure 3-5. Demonstrates facility of outflow alteration during 12-month period in each group of 
patients separately. (The vertical bars represent range; the boxes outer border shows the25 and 
75-percentiles and the thick middle line represents the median)* statistically significant 
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Overall baseline TOF was weakly correlated to TOF at 3-month post 





Figure 3-6. illustrates Pearson correlation on the scatter plot between baseline TOF and 3 months 
after surgery TOF. p=0.05, r=0.40 
 
 
We identified five patients (with cataract) who did not undergo any intraocular 
surgery in their contralateral eyes during the follow up period and used their 
data as comparison. The average age of this group was 64.4±7.4 years. They all 
had open angles on gonioscopy (Shaffer grading of 3 or 4 in all quadrants) with 
mean anterior chamber depth of 2.98±0.62 mm. The baseline IOP for this group 
was 18.0±2.09 mmHg, which did not change significantly at 3, 6 and 12 
months’ visits (15.2±1.90 mmHg at 3 months, p=0.84, 16.4±2.07 mmHg, 
p=0.21 and 16.8±2.71 -mmHg at 12 months, p=0.29) (Figure 3-7). 
  














































Figure 3-7. illustrates intraocular pressure changes during postoperative visits in the control group. 
* statistically significant 
 
 
Similarly, the facility of outflow at 3, 6 and 12 months compared with baseline, 
was not statistically different at any time point (0.18±0.08 vs 0.18±0.09 at 3 
months, p=0.1, 0.18±0.09 at 6 months, p=0.55 and 0.18±0.07 µl/min/mmHg at 
12 months, p=0.6) (Figure 3-8). 
 
Figure 3-8. demonstrates tonographic outflow facility changes during post-operative visits in the 





This is the first study to assess the facility of tonographic outflow after modern 
small incision phacoemulsification with intraocular lens implantation using 
electronic Schiøtz tonography. We demonstrated that IOP was significantly 
reduced at 3, 6 and 12 months after cataract surgery. In this study, the overall 
mean IOP reduction varied between 10 to 12%. There were also corresponding 
positive enhancement of TOF at all time points. 
Numerous studies have explored the effect of phacoemulsification cataract 
surgery on IOP; all demonstrated significant but variable fall in IOP (1.5 - 9.0 
mmHg) postoperatively (Slabaugh et al., 2014; Moghimi et al., 2017; Arthur et 
al., 2014; Shrivastava and Singh, 2010; Brooks and Gilles, 1992; Shingleton et 
al., 2006; Samuelson et al., 2011). However, current evidence is very limited on 
the effect of phacoemulsification on the facility of outflow. 
In the Ocular Hypertension Treatment Study (OHTS) the IOP reduction was 4.0 
mmHg three years after cataract surgery (Mansberger et al., 2012), which was 
greater than observed IOP reduction in our study at 12 months (2.0±3.6 mmHg). 
However, in the OHTS, baseline IOP was slightly higher (19.8±3.2 mmHg) 
compared to our cohort (16.0±3.7 mmHg). The IOP reduction after 
phacoemulsification has been shown to be proportional to the preoperative IOP, 
with significantly greater IOP reduction observed among those with higher 
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preoperative IOP (Pfeiffer et al., 2015); this may explain the greater IOP 
reduction in the OHTS group. 
A recent randomised control trial of a Schlemm’s canal micro stent (Hydrus II) 
with phacoemulsification in patients with open angle glaucoma, assessed 100 
patients (Pfeiffer et al., 2015). Cases were randomised to have either cataract 
surgery (CS) alone or CS with micro stent implant. In the CS group, washed-out 
IOP reduced from baseline of 26.6±4.2 to 17.4±3.7 mmHg at 12 months. The 
mean IOP reduction was 9.0 mmHg at 1 year. This study had much higher 
baseline IOP (26.6±4.2 mmHg) and consequently, greater observed IOP 
reduction (9.0 mmHg) at one year, compared to our study (2.0±3.6 mmHg) and 
OHTS (4.0 mmHg) (Eid, 2011). One should take into consideration the effect of 
regression to the mean phenomenon when interpreting a physiological values 
such as IOP which is known to fluctuate (Pfeiffer et al., 2015). 
Contrary to our study, Meyer and associates (Meyer et al., 1997) reported no 
enhancement of the facility of outflow at 6 weeks’ post phacoemulsification 
cataract surgery (baseline outflow facility of 0.39 ± 0.23 vs 0.37±0.16 µl/min. 
mmHg 6 weeks). This may partly be attributable to the inconsistency of 
pneumatonography technique used in their study, highlighted by their much 
higher than usual baseline outflow facility value compared to other historical 
data (Chen et al., 2015). 
 84 
Kee and Moon (Kee and Moon, 2000) carried out pneumatonography before 
and 2 months after phacoemulsification with intraocular lens implantation in 42 
patients with cataract. In this study, the IOP reduction was 2.4±0.4 mmHg at 2-
month post operatively. They demonstrated that outflow facility improved from 
0.26±0.01 to 0.30±0.01 µl/min/mmHg 2 months after lens extraction. Although 
the duration of that study was short, their findings are in agreement with our 
results at 3 months (0.14±0.07 pre-operatively vs 0.18±0.09 µl/min/mmHg at 
3-months). It is worth pointing out that the latter study did not report the 
anterior chamber depth or gonioscopy of their cases prior to the cataract 
surgery. One would assume that considering the higher prevalence of angle 
closure in the Korean population, narrow angle cases might have been included 
in their study inadvertently, making the effect of the lens removal on IOP 
reduction and the facility of outflow more exaggerated. 
Tonographic outflow facility encompasses changes in trabecular outflow 
facility, as well as any pressure-dependent changes to inflow (pseudo-facility) 
or uveoscleral outflow (R. F. Brubaker, 2004; Kupfer and Sanderson, 1968). 
Nonetheless, in our study we investigated the change in TOF before and after 
cataract surgery using the same measurement technique, which theoretically 
means that these potential confounding effect should be less of an issue. 
Although the most widely held view regarding the mechanism of IOP lowering 
effect post phacoemulsification is through increased trabecular outflow facility, 
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there were some speculations as to whether phacoemulsification may affect 
uveoscleral outflow as well as other aqueous humour dynamic parameters 
(Mathalone et al., 2005). In order to explore this, we made some calculations 
using the Goldmann’s equation (see Appendix); If we assume that other aspects 
of aqueous dynamic parameters, such as aqueous production (Ff), uveoscleral 
outflow (Fu) or episcleral venous pressure (Pe) are unlikely to be affected by 
phacoemulsification and the mechanism of IOP lowering effect of 
phacoemulsification cataract surgery is solely via the increase in trabecular 
outflow facility, then according to Goldmann’s equation, a 10-12% reduction in 
intraocular pressure (Pi) at all post op visits seen in our study should correspond 
to 11-18% increase in TOF (C) and this correlated well with our measured 
increase of 10-15% in TOF. As this largely accounts for the amount of IOP 
reduction, one can therefore conclude that the reason for the IOP drop post 
phacoemulsification is caused by an increase in trabecular outflow facility 
rather than any effects on other aqueous dynamic parameters such as 
uveoscleral outflow (see Appendix).  
In our study, there was no linear correlation between axial length, IOP and TOF. 
The available evidence generally corroborates our findings with regards to axial 
length and IOP (Lee et al., 2004; Guan et al., 2013; DeVience et al., 2017). 
However, there are no previous studies looking at the relationship between TOF 
and axial length. 
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However, the question remains as to the underlying mechanism for the increase 
in trabecular outflow facility. Both mechanical changes as well as modifications 
at the cellular level have been put forward as the potential reason for the 
increase in outflow facility post phacoemulsification (Shingleton et al., 2006; 
Wang et al., 2003; Tsuboi et al., 2012; Mehdizadeh, 2008; Zhao et al., 2016). 
Although this is outside the scope of this study, it is useful to describe these 
theories briefly. 
Based on the mechanical theory, the anterior chamber biometric alterations after 
phacoemulsification as well as other changes (Mehdizadeh, 2008; Zhao et al., 
2016), may have been responsible for the increase in trabecular outflow facility 
(Shingleton et al., 2006). Zhao et al. exhibited a significant expansion of the 
Schlemm’s canal based on optical coherent scans in eyes that had undergone 
phacoemulsification. Mehdizadeh also contemplated that the changes in the 
contractility of the ciliary muscles may have been accounted for the increase in 
trabecular outflow facility and the subsequent drop in IOP (Mehdizadeh, 2008). 
Per the cellular theory, proposed by Wang et al (Wang et al., 2003) and Tsuboi 
et al.(Tsuboi et al., 2012), ultrasound can induce chemical and cellular changes 
in vitro in cultured trabecular meshwork cells. However, another in vivo clinical 
studies failed to show a linear correlation between ultrasound energy and IOP 
reduction after cataract surgery (Lee et al., 2016). Siriwardena et al. 
(Siriwardena et al., 2000) showed that there is a prolonged presence of flare in 
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the anterior chamber after cataract surgery. This suggests that aqueous-blood 
barrier breakdown after cataract surgery may contribute to trabecular meshwork 
changes postoperatively. 
One limitation of our study is that POAG cases should have had a wash-out 
period from their glaucoma medications prior to study measurements. However, 
the number of medications which can affect trabecular outflow facility remained 
unchanged postoperatively. Furthermore, the results of the sub-group analysis 
were also similar to that of the combined data. However, because the numbers 
within each subgroup were small, the subgroup analysis should be interpreted 
with caution. Measurements collected from both eyes of an individual, are often 
correlated. Standard statistical tests such as t test, analysis of variance, 
confidence intervals and linear regression are only valid, if the parameters are 
independent (Sainani, 2010). Some studies have shown that including 
measurements from both eyes without adjusting for the correlation between two 
eyes have substantial effect on results (underestimates the standard error and 
generates falsely small p values) (Rosner, 1982). However, between-eye 
correlation can be exploited to include both eyes in some paired-eye studies 
(Beckman et al., 1990). The other approach is to take the average of 
measurements of two eyes (Newcombe and Duff, 1987; Murdoch, 1998). These 
approaches reduce information loss if the between-eye correlation is low. The 
choice of statistical approach depends on the research question. If the interest is 
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not eye specific, the individual level analysis might be the most appropriate 
method. In the present study I only include one eye per patient. 
To our knowledge, this is the first study to assess the tonographic outflow 
facility after small incision phacoemulsification cataract extraction and IOL 
implantation using electronic Schiøtz tonography (which is the least variable 
measurement technique compared to other techniques); with documented 
anterior chamber depth and gonioscopy. We demonstrated that the IOP drop is 
accounted for by the increase in tonographic outflow facility. However, the 
exact mechanism of the outflow facility enhancement remains unclear from this 
study. Further research is needed to elicit this important question. 
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Chapter 4| The aqueous humour dynamics changes in uveitic eye 
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This chapter is presented as a published paper and is an exact copy of the 
following journal publication. 
Pouya Alaghband, Alexander Jan Baneke, Elizabeth Galvis, et al. Aqueous Humor 




Uveitis is one of the most common ophthalmic conditions which is seen in eye 
departments globally. The prevalence of uveitis varies in different parts of the 
world (Acharya et al., 2013; Gritz and Wong, 2004; Suhler et al., 2008); 
however, idiopathic recurrent anterior uveitis (Chang and Wakefield, 2002; 
Miserocchi et al., 2013) is the most common diagnosis in those affected. One of 
the most serious sight threatening sequelae from this condition is uveitic 
glaucoma, which has a reported incidence of between 5 to 24% (Daniel et al., 
2017; Sallam et al., 2009; Sng et al., 2012; Friedman et al., 2013) amongst long-
term uveitic eyes. Despite the relatively high prevalence, there have only been a 
few previous aqueous humour dynamic studies exploring the pathogenesis of 
uveitic glaucoma in humans. This is partly due to measurement challenges 
which are unfortunately quite common in uveitic glaucoma/OHT cases. Firstly, 
eyes with prior intraocular surgery, such as cataract surgery, glaucoma filtration 
surgery or iridotomy/iridectomy, must be excluded. This is due to irido-
lenticular barrier compromise which subsequently may lead to excessive 
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posterior flow of fluorescein and thereby disrupt the fluorescein loss 
assumptions underlying the fluorophotometry measurements (Brubaker and 
McLaren, 1985; Gulati et al., 2011). Secondly, active uveitis can render the 
fluorophotometry measurements inaccurate. This is because of the presence of 
excessive protein in the anterior chamber which can bind with the fluorescein 
molecule and disrupt its natural clearance from the anterior chamber (Brubaker 
and McLaren, 1985; Gulati et al., 2011). 
Considering these limitations, it is not surprising that there have only been two 
previous human aqueous humour dynamics studies in uveitis or uveitic 
glaucoma/OHT and both were in those with active uveitis. The first study was 
by Ladas and associates (Ladas et al., 2001) who only investigated the 
correlation between tonographic outflow facility measured by Schiøtz 
tonography and laser flare photometry. However, they did not measure the 
aqueous flow rate. Their cohort comprised of patients with active uveitis (any 
type of uveitis including pan-uveitis and posterior uveitis were included). None 
of the eyes had any history of raised intra-ocular pressure (IOP). They showed 
that higher flare measurement in the anterior chamber coincided with lower 
outflow facility. 
The other study by Johnson et al. (Johnson et al., 1983), compared tonographic 
outflow facility (Schiøtz) and aqueous flow rate (fluorophotometry) in 10 eyes 
with cyclitis to their fellow healthy eyes. The results showed that the aqueous 
flow rate and facility of outflow were not significantly different compared to 
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unaffected fellow eyes. Only three cases had raised IOP at the time of the 
measurement. They also had some anterior chamber activity (trace to 2+ cells 
and flare in the anterior chamber was reported) which may have compromised 
the accuracy of the tonographic outflow facility and aqueous flow rate 
measurements. 
In regard to aqueous humour dynamics, there are probably three distinct 
circumstances where uveitis can lead to raised intra-ocular pressure; (1) those 
eyes that are currently actively inflamed, with anterior chamber inflammatory 
cells and proteins as well as concurrent steroid use; (2) previous severe or 
multiple uveitis attacks with a high likelihood of having had incisional ocular 
surgeries such as glaucoma filtration or cataract surgeries (such as juvenile 
chronic arthritis associated uveitis); (3) previous multiple but moderate anterior 
uveitis attacks but currently quiescent. 
As fluorophotometry can be inaccurate in eyes that are actively inflamed, we 
have therefore designed this study specifically investigating quiescent eyes of 
the last category of the aforementioned list. This helps us understand why some 
eyes develop uveitic glaucoma/OHT after only a few attacks of anterior uveitis 
and not others. 
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Materials and methods 
 
This study is a cross-sectional study comparing aqueous humour dynamics in 
age-matched healthy volunteers, previous anterior uveitis (without glaucoma) 
and those with uveitic glaucoma/OHT but no active uveitis at the time of study 
measurement. 
Ethical approval for this study was obtained from the local St Thomas’ Hospital 
research ethics committee. This research followed the tenets of the Declaration 
of Helsinki (http://www.clinical-trials.gov, identifier NCT02765308, 6th May 
2016). Healthy volunteers were recruited from the hospital staff and their family 
members after having a comprehensive ophthalmic examination. Patients with 
recurrent anterior uveitis were identified from our uveitis and glaucoma clinics 
at St Thomas’ Hospital, London, United Kingdom. A patient information leaflet 
was provided at the initial contact, and signed informed consent was obtained 
before glaucoma eye drop washout and study measurements took place. 
Participants enrolled in the study were divided into three groups (1) previous 
recurrent anterior uveitis (≥ 3 attacks) with glaucoma/OHT (uveitic glaucoma) 
on topical glaucoma drops treatment (group 1); (2) previous recurrent anterior 
uveitis (≥ 3 attacks) with normal IOP and no diagnosis of glaucoma (group 2); 
and (3) healthy volunteers (group 3). All uveitic eyes were quiescent at the time 
of enrolment (defined by absence of any flare/cells on slit lamp biomicroscopy). 
All patients in the uveitic glaucoma/OHT group had a 4-week washout period 
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from their anti-hypertensive and steroid treatments prior to their study 




• Age >18 years 
• Adequate cognitive function and ability to understand verbal and written 
information in English 
• Previous recurrent anterior uveitis (≥ 3 attacks) with/without 
OHT/glaucoma 
Exclusion Criteria 
• Other glaucoma diagnosis including pigment dispersion syndrome and 
pseudoexfoliation 
• Active uveitis 
• Ocular trauma 
• Intraocular or keratorefractive surgery 
• Use of systemic medication that may affect aqueous humour production 
such as beta-blockers 
• A history of allergy or hypersensitivity to fluorescein 
• Any abnormalities preventing reliable IOP or fluorophotometric readings 
Primary outcome measures 
 
• Tonographic outflow facility (measured by digital Schiøtz tonometry) 
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• Aqueous flow rate (measured by fluorophotometry) 
• Uveoscleral outflow (calculated from the Goldmann’s equation) 
Measurements 
 
All patients underwent clinical ophthalmic examinations including visual 
acuity, slit lamp biomicroscopy, gonioscopy, anterior chamber depth, and axial 
length measurement (IOL Master; Carl Zeiss Meditec Inc., Dublin, CA), central 
corneal thickness (CCT; Pachmate DGH 55, DGH Technology, Inc., Exton, 
PA), visual fields (Humphrey automated white-on-white, 24-2 SITA-standard; 
Carl Zeiss Meditec), and dilated ophthalmoscopy. The night before (10 PM) the 
fluorophotometric scans, participants self-administered from 3 to 6 drops of 
fluorescein sodium 2% (Minims; Bausch & Lomb, Kingston-upon-Thames, 
UK) topically into both eyes at 5-minute intervals depending on their ages (age 
< 26 years, 5 drops; age 26–35 years, 4 drops; >35 years of age, 3 drops) 
(Brubaker et al., 2001). Fluorophotometry was performed in both eyes with a 
scanning ocular fluorophotometer (FM-2, Fluorotron Master ocular 
fluorophotometer; OcuMetrics, Mountain View, CA) from 9 AM to 12 noon. 
The aqueous flow rate was determined using dedicated software provided with 
the fluorophotometer. Triplicate scans were collected and repeated at 1-hour 
intervals for four measurements to determine the aqueous flow rate (Ff). 
Following each set of scans, IOP was measured using pneumatonometry (Model 
30 Classic; Reichert Ophthalmic Instruments, Depew, NY); IOP was recorded 
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as the arithmetic mean of a total of 12 measurements per eye (3 measurements 
every hour for each eye). 
Tonographic outflow facility (C) was measured by constant weight tonography 
(5.5. 7.5 or 10 g) using a modified digital Schiøtz tonographer (designed by the 
Department of Bioengineering, Imperial College, London, UK) at 10 – 11 AM 
on the same day. Schiøtz tonography can affect the fluorophotometry by 
changing the fluorescence of the corneal epithelium; hence it is done towards 
the end of the study measurements. Our device used an original Schiøtz 
tonographer footplate from a commercially available unit (model 720, Berkeley 
Bioengineering Inc., San Leandro, CA, USA) attached to a 3D printed shell that 
was designed such that the weight conformed to the specifications set out by the 
Committee on Standardization of Tonometers (Friedenwald, 1954). 
Displacement of the weighted plunger was measured using a linear variable 
differential transformer (LVDT; MHR series, TE Connectivity, Schaffhausen, 
CH, USA) driven by a signal conditioner (AD698, Analog Devices, Norwood, 
MA, USA) and captured digitally by a data acquisition system (USB-6009, 
National Instruments, Austen, TX, USA). Validation studies confirmed that the 
LVDT voltage output was linear with respect to the Schiøtz scale reading 
(Figure 4-2), where each scale reading is equivalent to 0.05 mm of plunger 
displacement (Friedenwald, 1954). Facility was estimated using Grant’s 
equation (Equation 2) (Grant, 1950). 
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𝐶 =
𝑉𝑐,𝑡 − 𝑉𝑐,0 +
1




− 𝑃0 − Δ𝑃𝑣)  𝑡
          𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2 
where 𝑉𝑐,𝑡 and 𝑉𝑐,0 are the aqueous volumes displaced at time 𝑡 and at the start 
of tonography (𝑡 = 0). 𝑃𝑡,𝑡 and 𝑃𝑡,0 are values of IOP at time 𝑡 and at the start of 
tonography. 𝑃0 is the IOP immediately prior to the start of tonography. Δ𝑃𝑣 is 
the change in episcleral venous pressure, assumed to be 1.25 mmHg 
(Friedenwald, 1948), and 𝐾 is the coefficient of ocular rigidity, assumed to be 
0.0215/µl-1  (Moses and Becker, 1958). 𝑉𝑐,𝑡, 𝑉𝑐,0, 𝑃𝑡,𝑡 , 𝑃𝑡,0 and 𝑃0 were 
determined based on the value of the Schiøtz scale reading and tables provided 
by Moses and Becker (Moses and Becker, 1958). By minimising the root mean 
square error between the tonographic tracing ( 
Figure 4-3) and Equation 1 , the optimal value of 𝐶 was determined numerically. 
At present the clinical measurement of uveoscleral outflow in humans is not 
possible (Johnson et al., 2017); hence this value is generally calculated from the 
Goldmann’s equation. Sit and McLaren used a computerized venomanometry to 
measure episcleral venous pressure (EVP) (Sit and McLaren, 2011; Brubaker, 
1967). They illustrated that EVP in normal subjects can vary between 6 and 10 
mmHg. Therefore, we have used this EVP range for our calculations. However, 
to make this calculation valid, it must be assumed that the episcleral venous 
pressure did not vary significantly between all three groups of patients in our 
study. 
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Uveoscleral outflow was calculated using Goldmann’s equation (Equation 3) 
with an assumed episcleral venous pressure of 10 mmHg.  
“Ff” is the rate of aqueous humour formation measured by fluorophotometry, 
“C “is the tonographic facility of outflow, “Pi” is the intraocular pressure, “Pe” 
is the episcleral venous pressure, and “Fu” is uveoscleral flow. 
𝐹𝑓 =  (𝑃𝑖 − 𝑃𝑒)𝐶 +  𝐹𝑢                    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 3  
Therefore, 
    𝐹𝑢 = 𝐹𝑓 − 𝐶(𝑃𝑖 − 𝑃𝑒)   
Only one randomly (Excel random number generator; Microsoft, Redmond, 
WA) chosen eye per participant was included in the data analysis, when both 
eyes fulfilled the inclusion criteria. 
Sample size calculation 
 
The sample size estimate (30 patients/group) is based on the results of paired 
measurements of the three parameters in a previous study done at the Mayo 
Clinic by KSL (Lim et al., 2008). Using these estimates, and the adjusted alpha 
(0.0167), detectable differences for each of the 3 primary parameters of interest 
were calculated and the results are given in the following table: 









25% 5.4% 0.8 90% 
Facility of 
outflow 
37% 7.5% 0.1 90% 




Histograms and Shapiro-Wilk test were performed to test for normality of 
distribution of data. A Shapiro-Wilk W > 0.05 was evidence of normal 
distribution. Student’s t -test was used to compare continuous variables among 
groups. When data did not follow normality, non-parametric methods of 
analysis (Mann-Whitney U and Kruskal-Wallis tests) were used. Correlation 
coefficient analysis was used to determine the association of one parameter 
versus another parameter of aqueous humour dynamics. P<0.05 was considered 
statistically significant (all analyses, SPSS 24.0; SPSS, Chicago, IL). 
Results 
We screened one hundred and one patients between February 2014 and 
February-2017. Nine patients did not meet the inclusion criteria. Thirty patients 
with recurrent anterior uveitis and being treated for secondary glaucoma/OHT 
(group-1) and 32-patients with previous recurrent anterior uveitis (group 2) 
without OHT or glaucoma and with normal IOP who met the 
inclusion/exclusion criteria were recruited. Thirty healthy volunteers were 
enrolled as controls (group-3) over the same period. There was a female 
preponderance in groups 2 and 3. Most subjects were white Caucasians with a 
few African/Caribbean and Asians in groups 2 and 3 but a slightly higher 
presence of African/Caribbean patients in group 1 (p=0.06). The mean age in all 
3 groups were comparable (p=0.3). The best corrected visual acuity in the 
uveitic glaucoma/OHT (group 1) was worse compared to other groups 
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(p=0.002). This was primarily due to lens opacity and severity of glaucoma in 
the group 1. Anterior chamber depth, axial length and central corneal thickness 
were similar across all groups (p=0.3). Visual field parameters were worse in 
group 1 compared to other two groups (p=0.05). All patients had open angles on 
gonioscopy with only five (17%) patients in group -1 with non-contiguous 
patchy peripheral anterior synechiae. The subjects baseline characteristics are 
summarised in Table 4-6. Baseline characteristics of all participants are shown. 
 
Table 4-6. Baseline characteristics of all participants are shown. Mean±SD is presented for each 
parameter. *statistical significance 
 
F: female, M: male, W: white, B: black, A: Asian, BCVA; best corrected visual acuity, CCT: central 




1 and Group 3 
 Comparison 
between Group 1 
and Group 2 
 Comparison 
between Group 2 
and Group 3 











P value 95% CI Group 3 
[Normal] 
(n=30) 





0.06 --- 24(80%): 
8(20%) 




(W: B: A) 
10: 13: 7 0.01 --- 22: 9: 1 0.01 --- 21: 5: 4  0.01 --- 








0.04±0.2 0.02* -0.2- -
0.01 




CCT, µm 552±37.0 0.6 -27.5- 
11.6 




ACD, mm 3.34±0.3 0.6 -0.3-
0.12 
3.26±0.4 0.3 -0.1- 0.4 3.49±0.3 0.06 -0.02- 
0.4 
AXL, mm 23.4±4.0 0.8 -1.2-
1.9 
23.8±1.4 0.5 -0.8- 2.3 24.2±1.5 0.8 -1.2-1.9 
MD, dB -3.79±6.1 0.1 -0.3-
4.3 
-1.80±2.4 0.05* 0.03-4.8 -1.36±1.8 0.9 -1.9-2.7 
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Mean IOP was significantly higher in the uveitic glaucoma/OHT group 
compared to the other two groups (p<0.001). The tonographic outflow facility 
(C) was markedly lower in the uveitic glaucoma/OHT group compared to the 
other two groups (p=0.005). 
However, aqueous flow rate was not statistically different between the three 
groups (2.47±0.9 (group 1) vs 2.18±0.9 (group 2) vs 2.32±0.8 (group 3) µl/min, 
p=0.3). Additionally, no significant difference in uveoscleral outflow (with 
assumed episcleral venous pressure of 10 mmHg based on Sit and McLaren’s 
work (Sit et al., 2011)) was detected between the three groups (p=0.9). The full 
aqueous humour dynamic results are shown in Table 4-7. 
Table 4-7. Aqueous humour parameters and comparison made between all 3 groups. Mean±SD is 
presented for each parameter. *statistical significance 
 Comparison 
between Group 
1 and Group 3 
 Comparison 
between Group 
1 and Group 2  
 Comparison 
between 
Group 2 and 
Group 3 
 Group 1 [Uveitic 
glaucoma/OHT] 
(n=30) 
















































0.49±1.6  0.9 -0.73-
1.02 
0.64±1.3  0.7 -0.62-
1.15 
0.75±1.4  0.9 -0.75-
0.99 
IOP: intraocular pressure, OHT: ocular hypertension. FU: calculated uveoscleral outflow assumed Episcleral 
venous pressure of 10 mmHg  
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A break-down of different uveitis diagnoses in groups 1 and 2 are provided in 
Table 4-8. Most cases were idiopathic anterior uveitis. 
Table 4-8. The uveitis diagnosis in groups 1 and 2 are shown here 
 







21 4 3 0 1 1 
Group 2 
(n=32) 
22 2 7 1 0 0 
 
The study eyes in the group 1 on average had 4.5 episodes (range 3-6) of uveitis 
attacks whilst eyes in the group 2 had on average 6 episodes (range 3-10) prior 
to study measurements. 
If, rather than including all individuals in the uveitic glaucoma/OHT group as in 
Table 2, we excluded 14 individuals who maintained a normal IOP (< 21 
mmHg) post washout, the average IOP in the uveitic glaucoma/OHT group 
increased to 31.8±9.7 mmHg, which was greater than either the uveitis group 2 
(16±2.5 mmHg) and control group 3 (16±2.2 mmHg; p<0.001). 
Correspondingly, the tonographic outflow facility in the uveitic glaucoma/OHT 
group excluding those with normal IOP post-washout was 0.13±0.1 
µl/min/mmHg, which was significantly lower than either the uveitis group 2 
(0.27±0.1 µl/min/mmHg) or control group 3 (0.25±0.1 µl/min/mmHg; 
p<0.001). Nonetheless, even after removing those with normal post-washout 
IOP, there was still no statistically significant difference in aqueous flow rate 
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between three groups (2.42±0.9 (group-1) vs 2.18±0.9 (group 2) vs 2.32±0.8 
µl/min (group 3), p=0.4). Similarly, the uveoscleral outflow was comparable 
between all groups (-0.01±2.06 vs 0.64±1.3 in uveitis (group 2) vs 0.75±1.4 in 
controls (group 3), p=0.1). 
Correlation was made between IOP and aqueous flow rate, tonographic outflow 
facility, uveoscleral outflow, ACD or AXL. Only the correlation between 
post-washout IOP and tonographic outflow facility was statistically significant 
with a strong negative correlation observed in group 1 (R2=0.86, p<0.001). The 
other correlations were not significant (p>0.09) (Figure 4-1). However, 
correlation between IOP and aqueous humour parameters was not significant in 
other groups (P=0.6). 
Figure 4-1. Intraocular pressure (IOP) vs tonographic outflow facility plot. Correlation was made 
between post washout IOP and tonographic outflow facility. Only the correlation between post 
washout IOP and tonographic outflow facility was statistically significant with a strong negative 
correlation observed in group 1 (R2=0.86, p<0.001)[shown in light gray]. The other correlations 




This is the first aqueous humour dynamic study in patients with uveitic 
glaucoma/OHT and recurrent anterior uveitis compared with age-matched 
healthy controls. However, one should be mindful of the fact that uveoscleral 
outflow was calculated by the Goldmann formula using assumed episcleral 
venous pressure. Additionally, we utilised indirect techniques to measure the 
aqueous flow rate and tonographic outflow facility. Consequently, these 
parameters may have been compromised by subclinical inflammation. The 
uveitis and uveitic glaucoma/OHT cases were all clinically quiescent at the time 
of enrolment and none in the uveitic glaucoma/OHT group had more than six 
previous anterior uveitis attacks. We demonstrated that the elevated intraocular 
pressure seen in the uveitic glaucoma/OHT eyes was due to reduced 
tonographic outflow facility (this is used as a proxy of measuring trabecular 
outflow facility (Moses et al., 1985)). The aqueous flow rate was not detectibly 
different amongst the 3 groups nor did the calculated uveoscleral outflow 
demonstrated any difference between three groups. 
This study is unique in several aspects. Firstly, it encompasses age-matched 
healthy controls as well as those with previous recurrent anterior uveitis with or 
without glaucoma/OHT. Additionally, in this study, previously treated uveitic 
glaucoma/OHT patients underwent a 4-week washout period from their 
glaucoma medications, mydriatics and steroids before the study measurements. 
It is therefore suggestive that the reason for raised intraocular pressure, after 
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moderate number of recurrent anterior uveitis attacks, is caused by increased 
tonographic outflow resistance without significant impairment to aqueous 
production. 
Although the reduction in tonographic outflow facility in our finding should not 
come as a surprise (as in almost all other types of glaucoma, tonographic 
outflow impairment is the primary cause of raised IOP (Brubaker, 1991), this is 
the first study to confirm this in uveitic glaucoma. Ladas and associates (Ladas 
et al., 2001) investigated the correlation between outflow facility measured by 
Schiøtz tonography and laser flare photometry in patients with active uveitis. 
They demonstrated that the higher the measured flare in the anterior chamber 
(>20 photon units/msec), the lower the outflow facility (0.21±0.12 
µl/min/mmHg). They also reported that patients with flare <20 photon 
units/msec had a similar outflow facility to normal controls. Although increased 
aqueous protein level may lead to obstruction of trabecular meshwork pores in 
the acute phase, it may also have lasting effect on outflow facility as 
demonstrated by Epstein et al. (Epstein et al., 1978). They explored the facility 
of outflow in enucleated human eyes by infusing the eyes with human plasma 
and showed that facility of outflow reduced by over 40% and interestingly this 
was not resolved by irrigating the eyes with balanced salt solution. The authors 
speculated that this may be due to adhesion of serum components of plasma to 
the aqueous outflow system i.e. trabecular meshwork.  
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All uveitic glaucoma/OHT eyes in our cohort had clinically quiescent anterior 
chamber on slit lamp examination (although they may had subclinical 
inflammation; we did not have access to flaremeter to measure this) at the time 
of measurements; Nonetheless, there might have been lasting damage to TM 
due to repeated anterior chamber inflammation or even previous long-term use 
of topical steroids which can eventually cause compromised trabecular-outflow 
and consequently raised IOP. Mechanical obstruction due to peripheral anterior 
synechiae could also account for some of the reduced tonographic (trabecular) 
outflow facility. The evidence from animal studies suggests that inflammatory 
cells can cause blockage of trabecular outflow facility by simply clogging the 
trabecular meshwork pores (Rao et al., 1979). Chronic inflammation of the 
trabecular meshwork may lead to scar formation and permanent damage to the 
underlying tissue (Moorthy et al., 1997). In a recent multicentre study of risk 
factors of ocular hypertension in non-infectious uveitis (Daniel et al., 2017), the 
presence of peripheral anterior synechiae (PAS) carried a three-fold increased 
risk of developing OHT. Whilst in our study only 17% of uveitic 
glaucoma/OHT cases had some degree of non-contiguous PAS and none had 
more than 180 degrees of PAS, suggesting that raised IOP might have been due 
to micro-structural damage to the trabecular meshwork. Additionally, 
extracellular matrix accumulation in the trabecular meshwork or increased 
extension of the endothelial basement membrane along Schlemm’s canal 
coincide with long-term use of steroids may play a part in obstruction of 
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trabecular outflow and subsequently raised intraocular pressure (Johnson et al., 
1997; Overby et al., 2014). 
Calculated uveoscleral outflow in our present study in human uveitic 
glaucoma/OHT (as a non-invasive direct clinical measurement remains elusive) 
is in marked contrast to uveoscleral outflow measured in monkeys’ eyes with 
active uveitis by Toris and Pederson (Toris and Pederson, 1987). In their study 
using cynomolgus monkeys, the anterior uveitis was artificially induced with 
intra-cameral injection of albumin. The aqueous flow rate and uveoscleral 
outflow was measured using fluorescein isothiocyanate (FITC) dextran 70. 
They found that the uveoscleral outflow was four times greater in the inflamed 
eyes than the controlled eyes. In actively inflamed monkey eyes,  ciliary body 
becomes oedematous and supra-choroidal space is enlarged and there is surge in 
the release of endogenous prostaglandins (Yousufzai et al., 1996). Therefore a 
transient increase in uveoscleral outflow is observed which subsides once the 
inflammation has settled as in our study. Based on this observation, the authors 
would like to speculate that topical prostaglandin is more likely to be effective 
in lowering IOP in quiescent eye than in active uveitis eye (Bhattacherjee, 
1989). 
Post-operative hypotony after glaucoma filtration surgery in uveitic glaucoma 
has been routinely attributed to ‘aqueous shutdown’ without any evidence to 
substantiate this claim (Da Mata et al., 1999; Rumelt, 2013; Tran et al., 2000). 
Therefore, one of the most interesting findings in our study is the similar level 
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of aqueous flow rate (in the absence of active inflammation) in all three groups. 
This suggests that after less than seven attacks of anterior uveitis, there may not 
be any significant damage to the ciliary epithelium and other associated 
apparatus involved in the production of aqueous in human eyes. We limited our 
uveitis groups to only those eyes with more than three attacks of anterior uveitis 
and interestingly, none of our recruited cases in group 1 had more than six 
attacks of uveitis. We identified many other cases of uveitic glaucoma with 
more than 6 previous attacks, but none were eligible for our study due to 
previous intraocular surgeries, such as cataract and glaucoma surgeries. It is 
therefore plausible that uveitic glaucoma patients who have more than six 
attacks of uveitis may have different aqueous dynamic parameters, including 
aqueous production rate change. 
Based on available evidence and our own study, aqueous flow rate is probably 
only reduced in those cases of severe acute uveitis or those eyes with previous 
multiple (more than 6) and severe uveitis attacks, such as those associated with 
idiopathic juvenile arthritis. Therefore, surgical techniques (Gedde et al., 2018), 
rather than ‘aqueous shutdown’ are the most likely cause of hypotony post-
-glaucoma filtration surgeries, in those glaucoma eyes with moderate uveitis. 
However, it is difficult to substantiate this because of the limitations of current 
aqueous humour techniques in eyes which have undergone previous glaucoma 
surgery. 
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As part of the wash-out process before the aqueous humour dynamics 
measurements, we also observed an interesting finding in our study which may 
have significant clinical ramifications. After washout, the mean IOP in nearly 
half (47%) of the uveitic glaucoma/OHT group was less than 22 mmHg. It is 
likely that following a period of inactivity of the uveitis as well as cessation of 
topical steroid treatment, in those cases of presumed uveitic glaucoma/OHT, 
IOP may revert to normal after wash-out. Clinically, it is therefore sensible to 
consider treatment washout in this group of patients after these eyes have been 
controlled on glaucoma drops treatment after 6-12 months without any 
recurrence of their uveitis. 
 
There are, however, a few inherent limitations in aqueous humour dynamics 
studies. The most important of all is that the eyes undergoing fluorophotometry 
measurements should not have had any intraocular surgery such as cataract 
surgery or iridotomy, which may compromise the irido-lenticular barrier to the 
posterior flow of fluorescein during fluorophotometry measurement (Brubaker 
and McLaren, 1985; Gulati et al., 2011). Active uveitis also renders the 
fluorophotometry measurement inaccurate due to the presence of excessive 
protein in the anterior chamber which can bind to fluorescein molecules. 
Furthermore, with the breakdown of the blood-aqueous barrier, fluorescein can 
diffuse through unconventional pathways, potentially distorting the assumptions 
about the standard diffusional loss of fluorescein during fluorophotometry 
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(Brubaker and McLaren, 1985; Gulati et al., 2011). Tonographic outflow 
facility is influenced by ‘Pseudofacility’ especially in uveitis due to possible 
subclinical inflammation (Moses et al., 1985). Therefore, there might be a 
discordance between tonographic outflow facility and trabecular outflow 
facility. Another issue relates to the measurement of episcleral venous pressure 
and uveoscleral outflow. At present the precise measurement of uveoscleral 
outflow is not possible in humans (Johnson et al., 2017); hence this value is 
generally calculated from the Goldmann’s equation. As we are also unable to 
accurately measure the episcleral venous pressure (EVP)(Sit et al., 2011; 
Brubaker, 1967) despite some experimental methods of measuring EVP (Sit et 
al., 2011), they are not widely available. Therefore, it is generally accepted that 
EVP to be approximately 10-mmHg in humans. To make this calculation valid, 
it must be assumed that the EVP in these three groups of patients did not vary 
significantly. We did not perform flare measurement in our patients as we did 
not have the flare meter in our department; however, as we have taken great 
care in excluding any eyes with active uveitis, we do not believe that this 
measurement will affect the main findings of our study. 
In summary, to our knowledge this is the first aqueous humour dynamic study 
in patients with previous recurrent anterior uveitis and uveitic glaucoma/OHT 
compared with age-matched healthy controls. We have demonstrated that 
elevated intraocular pressure seen in the uveitic glaucoma/OHT eyes (after less 
than seven previous attacks of uveitis) was due to reduced tonographic outflow 
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facility alone. The aqueous humour flow rate was not detectibly different among 
the three groups nor did the calculated uveoscleral outflow demonstrate any 
detectible difference between the three groups. Clinicians should also consider 
treatment washout for those with medically treated uveitic glaucoma in the 
future. However, future studies should be undertaken once we have better 
techniques of aqueous dynamics measurements in eyes with active uveitis and 
previous intraocular surgeries as well as non-invasive and accurate techniques 
for measuring EVP and uveoscleral outflow. 
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Figure 4-2 Displacement calibration of the digital Schiøtz tonographer. Using a micrometre, 
the plunger of the LVDT was moved in increments of 50 µm, equivalent to 1 Schiøtz scale 
reading, over the range of -1 to 20 scale readings, whilst measuring the LVDT voltage output 
(supplemental Figure 1). Each position was measured 3 times, with all data shown. The 
voltage-displacement relationship was linear over the full range (R2 = 0.9997), allowing the 
measured LVDT voltage to be converted into a Schiøtz scale reading. A scale reading of -1 is 
defined as the reading when the footplate is placed on a rigid spherical surface with a 15 mm 




Figure 4-3 sample tonography tracing fit to Equation 1. The black trace shows the captured 
signal from the LVDT, converted into Schiøtz scale reading (see Figure 4-2 ). The red curve 
shows the predicted scale reading based on fitting Equation 1 to the black tracing for the 
optimal value of C (in this case 0.31 µl/min/mmHg). Tonography was performed with a 5.5-
-gram weight placed on the right eye of a uveitic patient without or ocular hypertension 
(IOP= -16.4 mmHg) glaucoma. The high frequency oscillations (~1 Hz) observed in the 




Chapter 5| The effect of high intensity focused ultrasound on 
aqueous humour dynamics 
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This chapter is presented as a published paper and is an exact copy of the 
following journal publication. 
 
Pouya Alaghband, Elizabeth Galvis, Alba Ramirez, et al. The Effect of High-Intensity 
Focused Ultrasound on Aqueous Humor Dynamics in Patients with Glaucoma. 
Ophthalmology Glaucoma 2020; 3 (2), 122-129 
 
Introduction 
Cyclodestructive procedures for glaucoma were introduced into clinical practice 
nearly a century ago (Vogt, 1936). Their primary aim is to ablate the ciliary 
epithelium which produces aqueous humour to reduce intraocular pressure 
(IOP). Various modalities have been used to achieve this goal, including: 
diathermy (Vogt, 1936), surgical excision (Verhoeff, 1924), cryotherapy 
(Beckman et al., 1972), and laser (Beckman and Sugar, 1973). Laser is now the 
most popular treatment method, using 810 nm diode laser, delivered either as 
trans-scleral diode photocoagulation (TSCP) (Weekers, 1924; Kosoko et al., 
1996) or endoscopically via endocyclophotocoagulation (ECP) (Chen et al., 
1997; Charles, 1981). 
The other treatment option is to utilize ultrasound energy to modulate ciliary 
epithelium function. High-intensity focused ultrasound (HiFU) was first used to 
treat brain pathologies, such as Parkinson’s disease in 1940s (Lynn and Putnam, 
1944). The theoretical advantage of this technology is to have the treatment area 
focused on a well-defined section at a pre-set depth, thus limiting damage to 
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surrounding tissues (Lynn and Putnam, 1944). This technology was later used in 
ophthalmology practice to treat glaucoma in 1980s. Coleman and his colleagues 
(Lizzi et al., 1984; Coleman et al., 1986) conducted first studies using a 
commercially available device called Therapeutic Ultrasound System 
(Sonocare-Inc., Ridgewood, New Jersey, USA). They evaluated the efficacy 
and safety of high-intensity focused ultrasound (HiFU) in patients with 
uncontrolled IOP and advanced glaucoma (Coleman et al., 1985; Lizzi et al., 
1984) with reasonable results. Similar outcome was later confirmed by another 
clinical study by Sterk et al. (Sterk et al., 1989). However, despite the 
encouraging initial evidence, the significant risk of complications, such as 
scleral staphyloma and perforation, corneal thinning, persistent hypotony, 
phthisis bulbi, and loss of visual acuity, led to abandonment of the procedure in 
the middle of 1990s (Maskin et al., 1989; Sterk et al., 1992, 1989). 
Additionally, the bulky design and complexity of the procedure were amongst 
other reasons for not pursuing this procedure further (Muratore, 2005). By 
refining the transducer design and the modes of energy delivery, Eye Tech Care 
(Rillieux- la-Pape, France) introduced a new ultrasound cycloplasty device 
using HiFU technology, called the EyeOP1 in 2011 (Charrel et al., 2011). This 
device has received CE mark in 2011 and Chinese FDA (CFDA) approval in 
2017. The device delivers ultrasound energy to the ciliary body with pre-set 
parameters. This device consists of a console, treatment probe and the coupling 
cone. The probe consists of 6 miniature piezoelectric curved areas inside the 
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probe which create well circumscribed areas of treatment on the eye. The high 
frequency enables focused delivery of ultrasound. The focusing area is not more 
than 0.1 by 1 mm2. The device pre-set parameters are 21 MHz frequency and 
2.45 W acoustic power with activation period of 8-second. The HiFU probe is 
supplied in three sizes (11, 12, and 13-mm), which fit most ocular sizes, and for 
every patient, the choice of the right size is based directly on white-to-white and 
axial length measurements (Denis et al., 2015). 
Initial reports suggested that HiFU has a comparable mechanism of action as 
other cyclodestructive procedures such as trans-scleral diode photocoagulation 
(TSCP) which lowers IOP by destroying ciliary processes and suppressing 
aqueous production (Denis et al., 2015; Aptel et al., 2010). However, 
Coleman-et-al. (Coleman et al., 1997) speculated that the focused ultrasound 
may have dual effects in reducing IOP by increasing outflow through the sclera 
from the induced scleral thinning. Mastropasqua et al. (Mastropasqua et al., 
2016), in a study used anterior segment optical coherence tomography (AS-
OCT) and in-vivo confocal microscopy. They indirectly assessed the uveo-
scleral outflow pathway via scleral changes (as a surrogate for uveo-scleral 
outflow pathway) post HiFU treatment in glaucoma patients. They found an 
increased intra-scleral hyporeflective spaces in AS-OCT. Authors contemplated 
that these findings were likely led to an increase in uveo-scleral outflow. 
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The aqueous humour dynamics effects of HiFU treatment has never been 
studied before. We have designed this case-control study assessing the effects of 
HiFU on aqueous humour parameters, to investigate the mechanism of action. 
Materials and methods 
 
Ethics approval for this study was obtained from the National Health Service 
(NHS) research ethics committee, United Kingdom. This research conformed to 
tenets of the Declaration of Helsinki (https://Clinicaltrials.gov identifier is 
NCT02839590. The NIHR portfolio registration number of this study is 35357). 
Consecutive patients with glaucoma or ocular hypertension (OHT) (glaucoma 
was defined as open angle glaucoma cases including pigmentary glaucoma 
diagnosed based on abnormal visual field testing and corresponding disc 
changes diagnosed by a glaucoma specialist) and sub-optimal IOP control 
despite maximum medical treatment, were invited to participate in the study. 
The rationale for including this group of patients was that HiFU is effective in 
managing refractory glaucoma (Melamed et al., 2015; F Aptel et al., 2016). A 
patient information leaflet was provided at the initial contact, and signed 





All of the following inclusion criteria were met: 
• All patients between the ages of 18 and 90 years 
• Diagnosis of open angle glaucoma or OHT with sub-optimal IOP control 
despite maximum medical treatment 
• Ability to undergo accurate fluorophotometry and tonography 
Patients were excluded if they had any of the following: 
• Mental impairment conflicting with informed consent or follow-up 
• Allergy to fluorescein 
• Current use of any investigational drug, device or current participation in 
an interventional clinical trial 
• Previous intraocular incisional surgeries including iridotomies, cataract 
surgeries or glaucoma filtration surgery 
All patients underwent a comprehensive ophthalmic examination including 
visual acuity, slit lamp examination, gonioscopy, anterior chamber depth, and 
axial length (IOL Master; Carl Zeiss Meditec Inc., Dublin, CA) measurement, 
central corneal thickness measurement (CCT; Pachmate DGH 55, DGH 
Technology-Inc., Exton, PA), visual fields (Humphrey automated white-on-
white, 24-2 SITA-standard; Carl Zeiss Meditec), and dilated ophthalmoscopy. 
Patients then underwent a 4-week wash-out period from all glaucoma treatments 
prior to baseline study measurements (patients had a safety visit, 2 weeks 
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post-washout). The washout process was repeated at 3-month visit, prior to 
study measurements (with a safety 2 weeks post washout visit). 
The night before the baseline study visit (10 PM) for the fluorophotometric 
scans, participants self-administered from 3 to 6 drops of fluorescein sodium 
2% (Minims; Bausch & Lomb, Kingston-upon-Thames, UK) topically into both 
eyes at 5-minute intervals depending on their ages (age 25 years and younger, 5 
drops; age 26–35 years, 4 drops; 35 years of age and older, 3 drops) (Brubaker 
et al., 2001). Fluorophotometry was performed in both eyes with a scanning 
ocular fluorophotometer from 9 AM to 12 noon (FM-2, Fluorotron Master 
ocular fluorophotometer; OcuMetrics, Mountain View, CA, USA). The aqueous 
flow rate was determined using dedicated software provided with the 
fluorophotometer. Duplicate or triplicate scans were collected and repeated at 1-
hour intervals for four measurements to determine the aqueous flow rate (Ft). 
Following each set of scans, IOP was measured using pneumatonometry (Model 
30 Classic; Reichert Ophthalmic Instruments, Depew, NY); IOP was recorded 
as the arithmetic mean of a total of 12 measurements per eye: 3 measurements 
every hour alternating between two eyes. 
Tonographic outflow facility (C) was measured by constant weight tonography 
(5.5 -10 g) using a modified digital Schiøtz tonographer (designed by the 
Department of Bioengineering, Imperial College London, London, UK) at 10 – 
11 AM. Our device used an original Schiøtz tonographer footplate from a 
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commercially available unit (model 720, Berkeley Bioengineering Inc., San 
Leandro, CA, USA) attached to a 3D printed shell that was designed such that 
the weight conformed to the standards set out by the Committee on 
Standardization of Tonometers (Friedenwald, 1954). Displacement of the 
weighted plunger was measured using a linear variable differential transformer 
(LVDT; MHR series, TE Connectivity, Schaffhausen, CH, USA) driven by a 
signal conditioner (AD698, Analog Devices, Norwood, MA, USA) and 
captured digitally by a data acquisition system (USB-6009, National 
Instruments, Austen, TX, USA). Validation studies (Alaghband et al., 2019) 
confirmed that the LVDT voltage output was linear with respect to the Schiøtz 
scale reading, where each scale reading is equivalent to 0.05 mm of plunger 
displacement. The procedure was then repeated (after 10 minutes) on the 
contralateral eye, with patching of the already tested eye (to prevent the cornea 
from drying out). 
At present the clinical measurement of uveoscleral outflow in humans is not 
possible (Johnson et al., 2017) ; hence this value is generally calculated from the 
Goldmann’s equation. Sit and McLaren (Sit et al., 2011) used a computerized 
venomanometry to measure episcleral venous pressure (EVP). They illustrated 
that EVP in normal subjects can vary between 6 and 10 mmHg. Therefore, we 
used this EVP range for our calculations. Uveoscleral outflow was calculated 
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using Goldmann’s equation (Equation 3) with an assumed episcleral venous 
pressure of 10 mmHg. 
“Ff” is the rate of aqueous humour formation measured by fluorophotometry, 
“C “is the tonographic facility of outflow, “Pi” is the intraocular pressure, “Pe” 
is the episcleral venous pressure, and “Fu” is uveoscleral flow (Equation 4). 
𝐹𝑓 =  (𝑃𝑖 − 𝑃𝑒)𝐶 +  𝐹𝑢. 
Equation 3. Goldmann equation 
Therefore  
𝐹𝑢 = 𝐹𝑓 − 𝐶(𝑃𝑖 − 𝑃𝑒)   




Three different probe sizes are available to account for differences in ocular 
anatomy. The probe size is determined for each patient, by optical biometry 
performed at baseline visit (measuring white-to-white diameter). A nomogram 
has been developed to facilitate white-to-white measurement to work out the 
probe size. 
A coupling cone made of a polymer is placed on the eye. This is to ensure the 
centration and distance from the eye is maintained throughout the procedure. At 
the base of the probe there is a suction cup to create low level vacuum 
(225-mmHg) to stabilise the cup on the eye. The 4-ml cavity that is created 
between the eye, cone and treatment probe is filled with sterile saline solution at 
room temperature (BSS, Alcon Inc., Fort Worth, TX, USA, or equivalent 
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product). The six elliptical cylinder-shaped impacts are centred on an 11–13 
mm diameter circle, depending on the ring diameter chosen, and spread over the 
eye circumference, while avoiding the nasal–temporal meridian. We used 
second-generation probe. This differs from the original version in its broader 
active transducer area (4 mm instead of 2.5 mm) and more precise temperature 
calibration of each single transducer. Other enhancements of the 
second-generation probe include optimised suction and centring on the eye 
globe; improved coupling of ultrasound due to removal of air bubbles in the 
liquid which could disturb the ultrasound beam; optimised ergonomics and 
improved clip to attach the probe into the cone. 
All HiFU procedures were performed by an experienced surgeon (KSL) under 
peribulbar anaesthesia (a mixture of lidocaine 2% and levobuprocaine 7.5%). 
However, the procedure can be carried out under subtenon anaesthesia too. 
Post-operatively, patients were treated topically with dexamethasone 0.1% 
preservative free 2 hourly for 2 weeks and then qds for 2 weeks. Hypotensive 
medications were stopped immediately postoperatively on the discretion of the 
treating clinician. 
 
Post op visits 
 
Patients were reviewed at 1 week, 1 month and then 3 months post operatively. 
The hypotensive topical drops may have been resumed at the discretion of the 
treating clinician. There was no washout at 1 week and 1-month post op. 
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However, all hypotensive treatments were stopped for 4 weeks prior to 3 
months’ aqueous humour dynamic measurements (patients had a 2-week safety 
visit after commencing the washout). 
Only one eye treated with HiFU (the worse eye affected by glaucoma/OHT) per 
participant was included in the data analysis. 
Primary outcome measures 
 
• Intraocular pressure (IOP) 
• Facility of tonographic outflow (measured by digital Schiøtz tonography) 
• Aqueous flow rate (measured by fluorophotometry) 
• Uveoscleral outflow (calculated from the Goldmann’s equation) 
These parameters were measured pre-treatment (after four weeks’ glaucoma 
treatment washout) and then at 3 months post-surgery (after four weeks’ 
glaucoma medication treatment washout). Measures were taken from the 





Histograms and Shapiro-Wilk test were performed to test for normality of 
distribution of data. A Shapiro-Wilk W > 0.05 was evidence of normal 
distribution. Student’s t-test was used to compare continuous variables among 
groups. When data did not follow normality, non-parametric methods of 
analysis (Mann-Whitney U and Kruskal-Wallis tests) were used. Correlation 
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coefficient analysis was used to determine the association of one parameter 
versus another parameter of aqueous humour dynamics. P < 0.05 was 
considered statistically significant (all analyses, SPSS 24.0; SPSS, Chicago, IL). 
 
Sample size calculation 
The sample size estimate (30 patients) is based on the results of paired 
measurements of the three parameters in a previous study done at the Mayo 
Clinic, Rochester, MN, USA, by the KSL (Lim et al., 2008). Using these 
estimates, and the adjusted alpha (0.0167), detectable differences for each of 
the -3 primary parameters of interest were calculated, and the results are given 
in the following table: 
 




Standard deviation Power 
IOP 20% 5% 2.2 90% 
Aqueous flow 25% 5.4% 0.8 90% 
Facility of 
outflow 
37% 7.5% 0.1 90% 
(Alpha=0.0167, two-sided t test of paired samples, 30 subjects) 
 
Results 
36 patients were invited to take part in this study. Three patients declined to 
participate, and another patient did not attend for their screening visit. One 
patient who had very high IOP after washout during safety visit was withdrawn 
from the study and had to have an urgent filtration surgery. One patient had 
satisfactory IOP after washout was also excluded from study. 
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Thirty eyes of 30 patients were included in the study. The study population 
comprised of predominantly African/Caribbean (n=18, 60%) and male (n=16, 
53%) patients. The baseline characteristics are shown in Table 5-9. Primary 
open-angle glaucoma was the main diagnosis. At the baseline study visit, the 
mean wash-out IOP was 31.7±5.3 mmHg with an average number of 
medications of 3.2±0.7 (median of 3). 
Thirteen fellow eyes of the recruited patients which did not receive any surgical 
intervention during or prior to the study formed the control group. 
Table 5-9. Baseline characteristics of treated and control eyes are shown here 
Mean±SD Treated eyes (n=30) Control eyes 
(n=13) 
P value 95% CI 
Age, years 60.1±13 60.3±13 0.7 -8.7 – 9.1 
Ethnicity 
(African/Caribbean: White) 
18: 12 7: 6 -- -- 
Diagnosis (OHT: POAG: PDG) 3: 26: 1 3: 10: 0 -- -- 
Gender (F: M) 14: 16 7: 6 -- -- 
BCVA 54.1±5.1 56.5±3.2 0.09 -5.3 – 0.4 
CCT, µm 529±38 547±39 0.6 -8.5-44.0 
ACD, mm 3.27±0.3 3.36±0.4 0.4 -0.1- 0.3 
AXL, mm 24.1±1.1 24.1±0.9 0.7 -0.8- 0.7 
WTW, mm 11.9±0.3 11.8±0.32 0.9 -0.3- 0.1 













<0.001* -11.7- -3.6 
OHT: ocular hypertension, POAG: primary open angle glaucoma, PDG: pigment dispersion glaucoma, CCT: central corneal thickness, 
ACD: anterior chamber depth, AXL: axial length, WTW: white-to-white, MD: Mean deviation,  
*statistical significance 
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The baseline aqueous humour dynamic measurements are shown in the Table 5-
10. There was no statistically significant difference in all the parameters 
between the treated and controlled group. 
Table 5-10. Baseline aqueous humour dynamics of the two groups 
 




P value  95% CI 
IOP (mmHg) 31.7±5.3 28.2±5.1 0.9 -0.7- 0.07 
Aqueous flow rate 
(µl/min) 
2.08±0.7 2.06±0.4 0.5 -0.6-0.3 
TOF (µl/min/mmHg) 0.14±0.09 0.12±0.09 0.6 -0.08-0.04 
Uveoscleral outflow 
(µl/min) 




HiFU treatment was performed in all 30 eyes. In all cases 6 sectors were treated 
except one patient who treatment was prematurely terminated by the operator 
whilst only 4 sectors were treated due to discomfort felt by the patient. Four 
patients experienced discomfort during the procedure, but it was perceived as 
mild to moderate and it did not cause interruption in treatment delivery.  
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Five subjects were considered as treatment failure (despite maximal medical 
therapy post HiFU treatment IOP remained suboptimal and they had to have 
glaucoma filtration surgery after HiFU application). A summary of treatment 
failure cases is shown in Table 5-11. 
Table 5-11. Summary of treatment failure cases 




















IOP* at 1 
months 
Number of 
meds at 1 
month 
1 PDG 40 White 4 28 40 33 2 46 3+ 
acetazolamide 
2 POAG 72 White 2 26 37 13 0 29 4+ 
acetazolamide 
3 POAG 74 African/Caribbean 4 23 33 14 0 27 4 
+acetazolamide 
4 POAG 45 African/Caribbean 3 25 30 10 0 45 3 
+acetazolamide 
5 POAG 53 African/Caribbean 4 24 37 22 0 28 3  
PDG: pigment dispersion glaucoma, POAG: primary open angle glaucoma. *IOP was 
measured with a Goldmann applanation tonometer 
Twenty-four patients completed 3-month aqueous humour dynamics 
measurements. One patient was lost to follow up and five patients had early 
treatment failure before 3 months wash-out and needed glaucoma filtration 
surgeries, and therefore withdrew from the study. 
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At 3-month post-operative visit (only cases who did not need any further 
glaucoma surgical interventions were considered), the mean post washout IOP 
was reduced by 16% (31.7±5.3 vs 26.6±4.8 mmHg, p=0.004) whilst aqueous 
flow rate was decreased by 15% (2.07±0.73 vs 1.77±0.55 µl/min, p=0.05) from 
baseline. Neither the tonographic outflow facility nor the uveoscleral outflow 
showed significant change from baseline. Table 5-12. illustrates primary 
outcome measures in the treatment group. The aqueous humour parameters 
remain unchanged at three months’ in the control group as shown in Table 5-13. 
 





3 months post 
operatively 
(n=24) 
P value 95% CI Effect estimate 
IOP (mmHg) 31.7±5.3 26.6±4.8 0.004 1.3-6.4 30.5 
Aqueous flow rate 
(µl/min) 




0.14±0.09 0.15±0.13 0.6 -0.07- 0.05 0.14 
Uveoscleral 
outflow (µl/min) 
-0.79±1.75 -0.53±1.76 0.6 -1.2-0.7 -0.78 
§ Wilcoxson signed ranked test, Bold font: statistically significant 
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Table 5-13. Aqueous humour parameters of the control group 
Mean±SD Baseline 
(n=13) 
3 months post 
operatively (n=13) 
P value 95% CI 
IOP (mmHg) 28.2±5.1 26.8±3.4 0.2 -0.7-3.5 
Aqueous flow rate 
(µl/min) 




0.13±0.08 0.13±0.08 0.3 -0.05- 0.03 
Uveoscleral outflow 
(µl/min) 
-0.16±1.57 0.1±1.57 0.3 -0.84-0.3 
 
 
Taking into account those five treatment failure eyes who were unable to 
undergo the 3 month’s washout visit, proportion of eyes achieving IOP 
reduction of >20% at 3 months’ wash-out visit compared to the pre-treatment 
wash-out IOP was 26.7% (n=8); for IOP reduction of >30%, the proportion of 
eyes was 10% (n=3). Table 5-14 summarises the peri- and post-operative 
complications.  
Table 5-14. shows the list of adverse events § led to incomplete treatment 
Lens opacity 1 
Scleral marks  4 
Pain during the procedure§ 4  
Persistent uveitis  1 
Punctate epithelial erosions 2 
Hypotony 0 
Visual loss (> 2 Snellen lines) 1 
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Discussion 
This is the first study investigating aqueous humour dynamics effect of a 
cyclodestructive procedure and specifically HiFU, in patients with uncontrolled 
open angle glaucoma on maximum tolerated medical therapy, and this is also 
the first washout study involving a cyclodestructive procedure. We 
demonstrated that there is a 20% risk of treatment failure (those who needed 
further glaucoma surgery intervention) within one month after a single HiFU 
treatment. Only 25 patients (80%) were able to undergo post-treatment washout 
measurements and in these eyes; HiFU reduced IOP 3-month postoperatively by 
16% whilst aqueous flow decreased by 15%. without any significant effect on 
tonographic outflow facility and uveoscleral outflow. Only 26.6% of eyes 
achieved >20% IOP reduction at 3 months compared to baseline. 
Ciliary body treatment for glaucoma has been available for over a century. The 
most obvious mechanism of action is the destruction of ciliary epithelium and 
subsequent reduction in aqueous humour production. Other possible adjunct 
mechanisms of action have been proposed such as increased uveoscleral 
outflow (Coleman et al., 1997) (external diode, Micro-pulse and HiFU) and 
flow through sclera (HiFU) (Mastropasqua et al., 2016). Although various 
indirect methods of measurements have strengthened this belief (Mastropasqua 
et al., 2016), there has never been any human aqueous humour dynamics study 
on the effect of ciliary body treatment. 
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Previous animal studies using HiFU in 18 rabbits’ eyes, reduced IOP by over 
50% four weeks after treatment (Aptel et al., 2010), while other clinical studies 
in human achieved between 25.5% and 38% of IOP reduction (F Aptel et al., 
2016; Melamed et al., 2015; Aptel and Cyril, 2015; Florent Aptel et al., 2016). 
However, none of these clinical studies performed wash-out from glaucoma 
medications prior to study measurements. The reason for the discrepancies in 
the extent of IOP reduction between previous studies and our results may well 
be due to better glaucoma treatment compliance post treatment and 
heterogeneity of glaucoma diagnoses in previous studies. We only included 
open angle glaucoma cases whilst others included secondary glaucoma cases 
with variable degrees of response to HiFU therapy. Additionally, we reviewed 
patients more frequently post HiFU and encouraged compliance. 
The most widely held view regarding the mechanism of IOP lowering effect 
post HiFU is through decreased aqueous production, which is consistent with 
our findings. However, there has been some speculations as to whether HiFU 
may affect uveoscleral outflow as well as other aqueous humour dynamics 
parameters (Mastropasqua et al., 2016). Mastropasqua et-al. (Mastropasqua et 
al., 2016) demonstrated anatomical alterations of sclera and conjunctiva four 
weeks after application of HiFU. They used these findings to contemplate that 
uveoscleral outflow enhancement may play a role in IOP reduction. However, 
the results from our aqueous humour dynamics measurement do not support this 
hypothesis. In fact, we did not find any statistically significant change in 
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uveoscleral and trabecular outflow 3 months’ after the HiFU treatment. 
Although earlier effects on other aqueous humour dynamics parameters such as 
uveoscleral outflow before our three months’ measurement cannot be ruled out 
by our study. 
In the aforementioned histological study of rabbits’ eyes which had underwent 
HiFU treatment, the authors (Aptel et al., 2010) described coagulation necrosis 
lesions in the ciliary processes post HiFU treatment. They observed the lesions 
were circumferentially distributed with the loss of the bi-stratified epithelium, 
and oedema and vascular congestion of the ciliary stroma without any 
histological changes to the scleral tissue adjacent to the treated area. These 
findings appeared to support the aqueous humour dynamics findings from our 
study of reduced aqueous flow rate. 
In order to explore if the aqueous flow rate change can fully account for the 
reduction in IOP at three months’, we made some calculations using the 
Goldmann’s equation (see Appendix 1); If we assume that other aspects of 
aqueous dynamic parameters, such as tonographic outflow facility (C), 
uveoscleral outflow (Fu) or episcleral venous pressure (Pe) are not affected by 
HiFU and the mechanism of IOP lowering effect of HiFU is solely via the 
decreased aqueous flow rate (Ff) alone, then according to Goldmann’s equation, 
a 16% reduction in intraocular pressure (Pi) at 3-month seen in our study should 
correspond to 15% decrease in aqueous flow rate (Ff) and this correlated well 
with our measured reduction of 12% in aqueous flow rate at 3 month. As this 
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largely accounts for the extent of IOP reduction, one can therefore conclude that 
the reason for the IOP drop post HiFU is likely to be caused by a decrease in 
aqueous flow rate alone (see Appendix 1). 
The current study has few limitations; firstly, we did not perform any aqueous 
humour dynamics study measurement prior to 3 months visit and there may 
have been changes in the other aspects of aqueous humour dynamics parameter, 
such as uveoscleral outflow then; however, aqueous flow measurement using 
fluorophotometry can be inaccurate in active uveitis. This is due to the presence 
of excessive protein in the anterior chamber and the breakdown of the blood 
aqueous barrier (during early postop period after HiFU) can distort the 
assumptions about the standard diffusional loss of fluorescein during 
fluorophotometry (Brubaker and McLaren, 1985). Furthermore, the use of 
topical steroid may potentially adversely affect the trabecular outflow (Overby 
et al., 2014; Johnson et al., 1997). We have therefore chose the three months’ 
timepoint as the first opportunity, after the cessation of topical steroid use and 
post-operative uveitis resolved to perform aqueous humour dynamics 
measurement. Secondly, none of our patients had repeat HiFU treatment. This is 
in contrast to all previous studies which patients had more than one application 
of HiFU treatment. Repeated treatment application may augment the effect of 
HiFU. However, as our primary interest was in the aqueous humour dynamics 
effects of HiFU treatment, repeated treatment would have caused further 
intraocular inflammation, thus delaying the aqueous humour dynamics 
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measurement further in some patients. The result of our study may not be 
generalizable to other types of cyclodestructive treatments such as cyclodiode as 
there may be a different mechanism of action due to laser light scatter and 
potentially wider treatment area. 
In conclusion, our study is the first clinical study to show aqueous humour 
dynamic changes after HiFU treatment. We confirmed that a three months’ 
post-HiFU treatment, reduction in aqueous production is the only aqueous 
dynamic parameters that could have accounted for the drop in IOP. 
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Appendix 1. Goldmann equation and calculations 
The aqueous production (flow) rate is equal to the sum of trabecular 
outflow and uveoscleral outflow 
𝐹𝑓 = (𝑃𝑖 − 𝑃𝑒). 𝐶 + 𝐹𝑢 
 
where, Ff is aqueous humour flow measured by fluorophotometry, Pi is 
intraocular pressure in the anterior chamber, Pe is the episcleral venous 
pressure, C is trabecular outflow facility measured by tonography and Fu is 
uveoscleral outflow. 
In this study, “Ff” was measured at baseline and at 3 months, while HiFU 
is assumed to have no effect on Fu, C and Pe. We considered C to be 
0.2-µl/min/mmHg, Fu to be 1 µl/min and Pe to be 8 mmHg. Therefore, a 16% 
drop in Pi, consistent with the IOP decrease observed at 3 months, should 








Within this thesis, I have explored the aqueous humour dynamics changes in 
uveitis and the effect of phacoemulsification and high intensity focused 
ultrasound. 
Within the discussion, research findings have been considered and related 
manuscripts have been included. However, in this chapter, a summary will be 
given to draw a conclusion on each finding of each individual project. 
Limitations will be discussed before reviewing the implications of the research 
and considering what direction the research and the field should go in the future. 
Each section below will give a brief summary of the different areas that this 
research has been based upon. When all information is gathered and culminated, 
then the findings can be discussed against previous and current research. 
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The effect of phacoemulsification on outflow facility  
 
There has been an explosion of new glaucoma procedures combined with 
cataract surgery called minimally invasive glaucoma surgery (MIGS). However, 
the effect of modern phacoemulsification on IOP has not been emphasised 
enough. In previous studies, it has been shown that IOP reduced after cataract 
surgery on average by 1.5-9 mmHg (this varies depending on the starting IOP 
prior to cataract surgery) (Slabaugh et al., 2014; Mansberger et al., 2012; 
Pfeiffer -et al., 2015). The higher the baseline IOP, the greater the IOP 
reduction. In a more recent study in Hydrus II trial, IOP was reduced in the 
phaco alone group by 9-mmHg (Pfeiffer et al., 2015). The cases had higher 
baseline IOP with consequently greater IOP reduction postoperatively. In my 
study, however, IOP was reduced by 2 mmHg only. Perhaps regression to mean 
phenomenon may be an explanation to this difference between studies (Pfeiffer 
et al., 2015). There have been several speculations about the mechanism of 
action for IOP reduction in cataract surgery especially in angle closure but not 
so much in open angle glaucoma (OAG). It has been proposed that chemokines 
and inflammatory molecules play important roles to improve IOP (Wang et al., 
2003; Tsuboi et al., 2012). Another hypothesis is the ultrastructural changes as a 
result of vibration of TM from phacoemulsification (Mehdizadeh, 2008; Zhao et 
al., 2016). All these suggest an improvement in the trabecular outflow facility. 
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In my study, I have demonstrated that IOP decreased by 12% after cataract 
surgery and it was maintained during the course of the study for a year. At the 
same time the TOF enhanced by 15% which corresponded with the amount of 
IOP reduction; that is with the assumption that EVP and aqueous flow rate 
remained unchanged after cataract surgery. This finding highlights the 
importance of the cataract surgery alone, in the management of OAG/OHT 
cases as a sole therapy. Further enhancement of IOP could be imagined if 
cataract surgery is combined with other procedures as it has been shown in the 
literature (Pfeiffer et al., 2015; Samuelson et al., 2011). 
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Aqueous humour dynamics in uveitic eyes 
 
Uveitis is potentially a blinding condition. This is mostly due to the 
development of uveitis sequlae such as glaucoma. The evaluation of uveitis 
influence on aqueous humour dynamics (ADS) changes can be challenging. 
This is due to active inflammation which can hamper the current techniques of 
measuring aqueous flow rate i.e. fluorophotometry (Brubaker and McLaren, 
1985). This method relies on the assumptions that the amount of fluorescein 
leakage through aqueous-blood barrier (ABB) is minimal/negligible. However, 
it is known that the ABB could be compromised in active uveitis (Toris and 
Pederson, 1987). The effect of uveitis on ADS has been under explored due to 
the above-mentioned reasons. To date there has been one animal study in 
monkey eyes to assess the ADS changes in uveitis. Toris and Pederson (Toris 
and Pederson, 1987), developed an experimental animal model of uveitis by 
injecting albumin in the monkey eyes. They showed that in the active phase the 
aqueous flow rate and trabecular outflow facility are decreased whilst the 
uveoscleral outflow is increased. Consequently, IOP was reduced, with some 
cases of hypotony. However, evaluating the ADS with non-invasive methods in 
humans in acute stages of uveitis has been proven to be challenging. To date 
there has been only two studies in humans. Johnston et al. (Johnson et al., 1983) 
performed ADS in Fuch’s-heterochromic cyclitis cases. They compared the 
ADS in the affected eyes with contralateral healthy eyes. They showed that the 
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aqueous flow rate (AF) remained unchanged. But the issue is that the ABB is 
not intact in FHC due to persistent anterior chamber flare/cells. Therefore, any 
attempt in measuring AF based on fluorescein clearance may not be accurate. In 
another study Ladas et al. (Ladas et al., 2001) performed flare meter and 
Schiøtz-tonography in uveitis eyes. They showed that the higher the flare, the 
lower the outflow. But in that study the AF was not measured. 
In my project three groups of patients were utilised: 
Group1: Uveitis with glaucoma/OHT 
Group 2: Uveitis with normal IOP 
Group 3: Healthy volunteers 
This was a cross-sectional study to investigate the effect of uveitis on aqueous 
humour parameters. All patients were clinically inactive at the time of the study 
measurements. They had wash-out of their glaucoma and steroid medications 
(in group 1). I demonstrated that in group-1, TOF was decreased whilst IOP was 
increased. However, uveoscleral outflow and aqueous flow rate remained 
unchanged across all three groups. Therefore, I proposed that the aqueous shut 
down after glaucoma operation in uveitic eyes might be inaccurate. However, 
this claim maybe challenging to substantiate and might be controversial. 
Consequently, a good filtration surgery would be sufficient to control IOP in 
patients with mild to moderate severity of recurrent uveitis. One interesting 
finding from my study was that nearly half of the patients (47%) in group 1, 
after the washout of their anti-hypertensive medications maintained normal IOP. 
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One recommendation from this would be to perform a trial of glaucoma 
medications washout after the subsidence of the acute phase of uveitis. 
However, those patients will still need close monitoring to ensure that any 
future IOP spike as a result of uveitis reactivation is treated swiftly and in 




The effect of high intensity focused ultrasound on aqueous humour 
dynamics 
 
High intensity focused ultrasound (HiFU) has been introduced into the clinical 
practice since the 1940’s. It was first used to treat Parkinson disease (Lynn and 
Putnam, 1944). Over the years, application of this modality has become 
broadened. HiFU was first utilised in ophthalmology by Jackson Coleman and 
colleagues in the 1980s (Lizzi et al., 1984; Coleman et al., 1986). They applied 
HiFU in a variety of pathologies including ocular oncology, retinal detachment 
and in glaucoma. The initial result of using Sonocare was very promising. 
However, the glories of the treatment were soon diminished due to a high rate 
of complication, cumbersome technique with a large device and inconsistent 
outcomes (Maskin et al., 1989; Sterk et al., 1992). HiFU was soon abandoned in 
the early 1990s. But in 2011 the EyeTech company revisited the idea of 
utilising HiFU in the glaucoma treatment (Charrel et al., 2011). The new device 
which is called EyeOP 1 was miniaturised and simplified. With the new and 
improved model, its success was more promising in early animal and human 
trials in the refractory glaucoma cases in blind eyes (Melamed et al., 2015; 
Aptel and Lafon, 2012; Aptel et al., 2014). This was then led to larger clinical 
trials to confirm the effectiveness of this treatment (F Aptel et al., 2016). 
However, the mechanism of action has not been fully understood. There has 
been only one study facilitating anterior segment OCT to assess the scleral 
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changes as a proxy for uveoscleral outflow alterations following HiFU. 
Mastropasqua et al. (Mastropasqua et al., 2016) demonstrated that one-month 
post HiFU treatment the number of the sizes of the scleral lakes increased and 
they used this as a proxy for uveoscleral outflow enhancements. 
The impact of HiFU on aqueous humour dynamics parameters has not been 
studied and the mechanism of action for HiFU has been broadly hypothesized. 
In my project the patients that were selected had OAG whose IOP was 
inadequately controlled; they were also due to have glaucoma filtration surgery. 
Patients had a washout from their hypotensive medications 4 weeks prior to 
their study visit, this was prior to the HiFU application. 
All patients had fluorophotometry and Schiøtz tonography. These 
measurements were repeated 3 months after treatment (patients had wash-out 
from their anti-glaucoma meds for 4 weeks prior to the study visit). At 3 months 
postoperatively, IOP was reduced by 16% and aqueous flow rate was reduced 
by 15%. However, there were no detectable changes in uveoscleral outflow and 
tonographic outflow facility. The level of IOP reduction was slightly lower than 
previous reports. One reason might have been due to the fact that the patients 
were only allowed to have one application of HiFU. This is in contrast to 
previous studies that patients had multiple applications of HiFU. Additionally, 
patients in this study had an anti-glaucoma medication washout prior to their 
study visit. The complete success in my study was (IOP reduction >20%) 
only-27%. I demonstrated that the calculated uveoscleral outflow remained 
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unchanged 3-month post treatment. Mastropasqua et al. (Mastropasqua et al., 
2016) showed some scleral changes 1 months after the HiFU treatment. They 
suggested that their findings might be a surrogate of enhanced uveoscleral 
outflow. One reason for this discrepancy of findings might be due to the fact 
that the early scleral alterations are transient effects of HiFU. Nonetheless, 
longer-term studies will be required. 
Contributions to the literature and implications 
 
The work in this thesis contributes significantly to what is known about the 
effect of phacoemulsification, HiFU and uveitis on the aqueous humour 
dynamics parameters. None of the previous studies have been as comprehensive 
(with the available technology). These studies further highlighted the 





Important limitations to this work must be acknowledged and have already been 
discussed in each chapter. The inherent flaws of the current aqueous humour 
dynamics measurements in humans have been discussed in detail in chapter 2. 
The Schiøtz tonography has its own limitations including several assumptions 
which govern the accuracy of the device. The accurate measurement of 
uveoscleral outflow and episcleral venous pressure is not currently possible. In 
this thesis the results have been based upon the assumed episcleral 
venous-pressure; that has been used according to measurements extracted from 
previous studies. The calculated uveoscleral outflow was worked out through 





Following the work of this thesis, there are a number of areas in which it would 
be interesting to investigate. 
Further collaborative work would lead to the development of more accurate and 
direct methods which are non-invasive to be carried out in humans. As it has 
been shown by the previous partnership in the development of the new digital 
Schiøtz tonography machine. It would be useful to conduct some non-invasive 
animal studies based on cannulations and direct methods. 
Secondly, uveitic glaucoma is a fascinating area that could be investigated 
further, particularly the ADS changes during the acute phase and in more severe 
cases of uveitis. However, the challenge is that acute inflammation limits the 
application of current techniques in measuring the aqueous humour dynamics. 
So, a technique which is direct and non-invasive would be ideal for active phase 
of inflammation. Another aspect to explore in the uveitic glaucoma is to 
consider performing laser flaremetry for clinically quiescent uveitis to establish 
subclinical activity of the disease. Additionally, it is crucial to monitor uveitis 
case who are on glaucoma medication very closely. This is to capture early IOP 
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Appendix. Goldmann equation  
The aqueous production (flow) rate is equal to the sum of trabecular 
outflow and uveoscleral outflow 
𝐹𝑓 = (𝑃𝑖 − 𝑃𝑒). 𝐶 + 𝐹𝑢 
 
where, Ff is aqueous humour flow measured by fluorophotometry, Pi is 
intraocular pressure in the anterior chamber, Pe is the episcleral venous 
pressure, C is trabecular outflow facility measured by tonography and Fu is 
uveoscleral outflow. 
In this study, “C” was measured at baseline and at 3, 6 and 12 months, 
while phacoemulsification is assumed to have no effect on Ff, Fu and Pe. We 
considered Ff to be 2.5 µl/min, Fu to be 1 µl/min and Pe to be 8 mmHg. 
Therefore, a 10% drop in Pi, consistent with the IOP decrease observed at 6 
months, should correspond to 18% increase in “C”. In addition, a 12% drop in 
Pi, should correspond to 13% increase in “C” at 3 months. Furthermore, we 
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